Guest guest Posted December 30, 2007 Report Share Posted December 30, 2007 Hi and Happy Happy to all, Here is a link to an article about the inconsistency in treatment regimens of PF patients after DX. As Bruce so loves to remind us and, he is so right, WE are in charge of our healthcare. My Pulmo considers me to be a pain in the backside ... my PCP however wishes all his patients were like me. http://www.mayoclinic.org/news2007-rst/4313.html?mc-emref=y My resolution for the New Year is to never give up and never give in. My wish for the New Year is that WE will have PEACE on earth. Peace be with you all! UIP/LCH 5.06 CA > > > > Thanks , > > That was really informative and for me it answered the > question of why prednisone works for some of us and not for others. > I thought all forms of PF were inflammatory and didn't realize IPF > was not. > > > > Sarcoid/PF 3/2006 California > > > > > > PF and Raynauds Disease > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > Long post here folks bear with me. > > > > > > > > Raynauds Syndrome is a vasospasmic disorder which affects between 5% > > > > to 10% of the US population. About 20% of women in their child > bearing > > > > years are afflicted. The disorder is more common among women than > men. > > > > > > > > There are two forms of the disease: > > > > > > > > Primary Raynauds is the most common form of the disease and usually > is > > > > of earlier onset. It is called Raynauds Disease (RD). It is of > unknown > > > > etiology. > > > > > > > > Secondary Raynauds is called Raynauds Phenomenon (RP). It is > > > > considered to be the more serious of the two and its onset is later > in > > > > life (third decade and out). RP like many forms of PF is considered > an > > > > inflammatory condition. Many forms of Pulmonary Fibrosis (PF), like > RP > > > > , are co-morbid or secondary diseases. > > > > > > > > Known causes of both RP and/or PF are: > > > > > > > > Collagen Vascular Disease, Connective Tissue Disease, Rheumatic > > > > Disease, Atherosclerosis, Auto-Immune Disease, Repetitive Stress > > > > Injuries, Trauma, Smoking, Medication and Chemotherapy exposure, > > > > Chemical exposure and, some Endocrine and Hormonal disorders. > > > > > > > > It is quite possible that many of us on this Board suffer from RP > and > > > > PF AND a PRIMARY co-morbid (co-existing) diagnosis. > > > > > > > > Last,in that UIP/IPF (usual interstitial pneumonitis / idiopathic > > > > pulmonary fibrosis)is NOT considered to be an inflammatory form of > PF > > > > and, is of unknown etiology it follows that if you suffer from > UIP/IPF > > > > and Raynauds it is more likely to be the less serious of the two RD > > > > and not RP. > > > > > > > > For me, my DX (5.06)is Usual Interstial Pneumonitis and Langerhans > > > > Cell Histiocytosis. I have had Raynauds Disease all my life. I find > RD > > > > to be distracting and inconvenient but never anything more than > that. > > > > > > > > UIP/LCH 5.06 CA > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > <!-- > > > > #ygrp-mkp{ > > border:1px solid #d8d8d8;font-family:Arial;margin:14px > 0px;padding:0px 14px;} > > #ygrp-mkp hr{ > > border:1px solid #d8d8d8;} > > #ygrp-mkp #hd{ > > color:#628c2a;font-size:85%;font-weight:bold;line- > height:122%;margin:10px 0px;} > > #ygrp-mkp #ads{ > > margin-bottom:10px;} > > #ygrp-mkp .ad{ > > padding:0 0;} > > #ygrp-mkp .ad a{ > > color:#0000ff;text-decoration:none;} > > --> > > > > > > > > <!-- > > > > #ygrp-sponsor #ygrp-lc{ > > font-family:Arial;} > > #ygrp-sponsor #ygrp-lc #hd{ > > margin:10px 0px;font-weight:bold;font-size:78%;line-height:122%;} > > #ygrp-sponsor #ygrp-lc .ad{ > > margin-bottom:10px;padding:0 0;} > > --> > > > > > > > > <!-- > > > > #ygrp-mlmsg {font-size:13px;font-family:arial, helvetica, clean, > sans-serif;} > > #ygrp-mlmsg table {font-size:inherit;font:100%;} > > #ygrp-mlmsg select, input, textarea {font:99% arial, helvetica, > clean, sans-serif;} > > #ygrp-mlmsg pre, code {font:115% monospace;} > > #ygrp-mlmsg * {line-height:1.22em;} > > #ygrp-text{ > > font-family:Georgia; > > } > > #ygrp-text p{ > > margin:0 0 1em 0;} > > #ygrp-tpmsgs{ > > font-family:Arial; > > clear:both;} > > #ygrp-vitnav{ > > padding-top:10px;font-family:Verdana;font-size:77%;margin:0;} > > #ygrp-vitnav a{ > > padding:0 1px;} > > #ygrp-actbar{ > > clear:both;margin:25px 0;white-space:nowrap;color:#666;text- > align:right;} > > #ygrp-actbar .left{ > > float:left;white-space:nowrap;} > > .bld{font-weight:bold;} > > #ygrp-grft{ > > font-family:Verdana;font-size:77%;padding:15px 0;} > > #ygrp-ft{ > > font-family:verdana;font-size:77%;border-top:1px solid #666; > > padding:5px 0; > > } > > #ygrp-mlmsg #logo{ > > padding-bottom:10px;} > > > > #ygrp-vital{ > > background-color:#e0ecee;margin-bottom:20px;padding:2px 0 8px 8px;} > > #ygrp-vital #vithd{ > > font-size:77%;font-family:Verdana;font-weight:bold;color:#333;text- > transform:uppercase;} > > #ygrp-vital ul{ > > padding:0;margin:2px 0;} > > #ygrp-vital ul li{ > > list-style-type:none;clear:both;border:1px solid #e0ecee; > > } > > #ygrp-vital ul li .ct{ > > font-weight:bold;color:#ff7900;float:right;width:2em;text- > align:right;padding-right:.5em;} > > #ygrp-vital ul li .cat{ > > font-weight:bold;} > > #ygrp-vital a{ > > text-decoration:none;} > > > > #ygrp-vital a:hover{ > > text-decoration:underline;} > > > > #ygrp-sponsor #hd{ > > color:#999;font-size:77%;} > > #ygrp-sponsor #ov{ > > padding:6px 13px;background-color:#e0ecee;margin-bottom:20px;} > > #ygrp-sponsor #ov ul{ > > padding:0 0 0 8px;margin:0;} > > #ygrp-sponsor #ov li{ > > list-style-type:square;padding:6px 0;font-size:77%;} > > #ygrp-sponsor #ov li a{ > > text-decoration:none;font-size:130%;} > > #ygrp-sponsor #nc{ > > background-color:#eee;margin-bottom:20px;padding:0 8px;} > > #ygrp-sponsor .ad{ > > padding:8px 0;} > > #ygrp-sponsor .ad #hd1{ > > font-family:Arial;font-weight:bold;color:#628c2a;font- > size:100%;line-height:122%;} > > #ygrp-sponsor .ad a{ > > text-decoration:none;} > > #ygrp-sponsor .ad a:hover{ > > text-decoration:underline;} > > #ygrp-sponsor .ad p{ > > margin:0;} > > o{font-size:0;} > > .MsoNormal{ > > margin:0 0 0 0;} > > #ygrp-text tt{ > > font-size:120%;} > > blockquote{margin:0 0 0 4px;} > > .replbq{margin:4;} > > --> > > > > > > > > > > > > > > > > > > > ______________________________________________________________________ > ______________ > > Looking for last minute shopping deals? > > Find them fast with Yahoo! Search. > http://tools.search.yahoo.com/newsearch/category.php?category=shopping > > > Quote Link to comment Share on other sites More sharing options...
Guest guest Posted December 30, 2007 Report Share Posted December 30, 2007 Very interesting article. What I find interesting too is that with the inconsistency I'll bet lots of those pulmonologists are still adamant over their way. At least mine said, some believe this and some believe that and talked about the options although not sure he understood my choices. Well, my pulmonologist probably believes I'm a pain. My PCP knows I am but he shows me respect because he knows how many times when I've felt there was a problem there turned out to be one. He didn't believe (and he basically admitted it later by not disagreeing when I said it) that I had a problem beyond being out of shape, but he still humored me and took precautions and checked. It just took one six minute walk and he realized I was right, that there was something else wrong. Schools here are increasing courses on talking and listening to patients and encouraging doctors to take continuing credit courses in the area, recognizing how much failing to do so well impacts their treatment. > > > > > > Thanks , > > > That was really informative and for me it answered the > > question of why prednisone works for some of us and not for others. > > I thought all forms of PF were inflammatory and didn't realize IPF > > was not. > > > > > > Sarcoid/PF 3/2006 California > > > > > > > > > PF and Raynauds Disease > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > Long post here folks bear with me. > > > > > > > > > > > > Raynauds Syndrome is a vasospasmic disorder which affects between 5% > > > > > > to 10% of the US population. About 20% of women in their child > > bearing > > > > > > years are afflicted. The disorder is more common among women than > > men. > > > > > > > > > > > > There are two forms of the disease: > > > > > > > > > > > > Primary Raynauds is the most common form of the disease and usually > > is > > > > > > of earlier onset. It is called Raynauds Disease (RD). It is of > > unknown > > > > > > etiology. > > > > > > > > > > > > Secondary Raynauds is called Raynauds Phenomenon (RP). It is > > > > > > considered to be the more serious of the two and its onset is later > > in > > > > > > life (third decade and out). RP like many forms of PF is considered > > an > > > > > > inflammatory condition. Many forms of Pulmonary Fibrosis (PF), like > > RP > > > > > > , are co-morbid or secondary diseases. > > > > > > > > > > > > Known causes of both RP and/or PF are: > > > > > > > > > > > > Collagen Vascular Disease, Connective Tissue Disease, Rheumatic > > > > > > Disease, Atherosclerosis, Auto-Immune Disease, Repetitive Stress > > > > > > Injuries, Trauma, Smoking, Medication and Chemotherapy exposure, > > > > > > Chemical exposure and, some Endocrine and Hormonal disorders. > > > > > > > > > > > > It is quite possible that many of us on this Board suffer from RP > > and > > > > > > PF AND a PRIMARY co-morbid (co-existing) diagnosis. > > > > > > > > > > > > Last,in that UIP/IPF (usual interstitial pneumonitis / idiopathic > > > > > > pulmonary fibrosis)is NOT considered to be an inflammatory form of > > PF > > > > > > and, is of unknown etiology it follows that if you suffer from > > UIP/IPF > > > > > > and Raynauds it is more likely to be the less serious of the two RD > > > > > > and not RP. > > > > > > > > > > > > For me, my DX (5.06)is Usual Interstial Pneumonitis and Langerhans > > > > > > Cell Histiocytosis. I have had Raynauds Disease all my life. I find > > RD > > > > > > to be distracting and inconvenient but never anything more than > > that. > > > > > > > > > > > > UIP/LCH 5.06 CA > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > <!-- > > > > > > #ygrp-mkp{ > > > border:1px solid #d8d8d8;font-family:Arial;margin:14px > > 0px;padding:0px 14px;} > > > #ygrp-mkp hr{ > > > border:1px solid #d8d8d8;} > > > #ygrp-mkp #hd{ > > > color:#628c2a;font-size:85%;font-weight:bold;line- > > height:122%;margin:10px 0px;} > > > #ygrp-mkp #ads{ > > > margin-bottom:10px;} > > > #ygrp-mkp .ad{ > > > padding:0 0;} > > > #ygrp-mkp .ad a{ > > > color:#0000ff;text-decoration:none;} > > > --> > > > > > > > > > > > > <!-- > > > > > > #ygrp-sponsor #ygrp-lc{ > > > font-family:Arial;} > > > #ygrp-sponsor #ygrp-lc #hd{ > > > margin:10px 0px;font-weight:bold;font-size:78%;line- height:122%;} > > > #ygrp-sponsor #ygrp-lc .ad{ > > > margin-bottom:10px;padding:0 0;} > > > --> > > > > > > > > > > > > <!-- > > > > > > #ygrp-mlmsg {font-size:13px;font-family:arial, helvetica, clean, > > sans-serif;} > > > #ygrp-mlmsg table {font-size:inherit;font:100%;} > > > #ygrp-mlmsg select, input, textarea {font:99% arial, helvetica, > > clean, sans-serif;} > > > #ygrp-mlmsg pre, code {font:115% monospace;} > > > #ygrp-mlmsg * {line-height:1.22em;} > > > #ygrp-text{ > > > font-family:Georgia; > > > } > > > #ygrp-text p{ > > > margin:0 0 1em 0;} > > > #ygrp-tpmsgs{ > > > font-family:Arial; > > > clear:both;} > > > #ygrp-vitnav{ > > > padding-top:10px;font-family:Verdana;font-size:77%;margin:0;} > > > #ygrp-vitnav a{ > > > padding:0 1px;} > > > #ygrp-actbar{ > > > clear:both;margin:25px 0;white-space:nowrap;color:#666;text- > > align:right;} > > > #ygrp-actbar .left{ > > > float:left;white-space:nowrap;} > > > .bld{font-weight:bold;} > > > #ygrp-grft{ > > > font-family:Verdana;font-size:77%;padding:15px 0;} > > > #ygrp-ft{ > > > font-family:verdana;font-size:77%;border-top:1px solid #666; > > > padding:5px 0; > > > } > > > #ygrp-mlmsg #logo{ > > > padding-bottom:10px;} > > > > > > #ygrp-vital{ > > > background-color:#e0ecee;margin-bottom:20px;padding:2px 0 8px 8px;} > > > #ygrp-vital #vithd{ > > > font-size:77%;font-family:Verdana;font- weight:bold;color:#333;text- > > transform:uppercase;} > > > #ygrp-vital ul{ > > > padding:0;margin:2px 0;} > > > #ygrp-vital ul li{ > > > list-style-type:none;clear:both;border:1px solid #e0ecee; > > > } > > > #ygrp-vital ul li .ct{ > > > font-weight:bold;color:#ff7900;float:right;width:2em;text- > > align:right;padding-right:.5em;} > > > #ygrp-vital ul li .cat{ > > > font-weight:bold;} > > > #ygrp-vital a{ > > > text-decoration:none;} > > > > > > #ygrp-vital a:hover{ > > > text-decoration:underline;} > > > > > > #ygrp-sponsor #hd{ > > > color:#999;font-size:77%;} > > > #ygrp-sponsor #ov{ > > > padding:6px 13px;background-color:#e0ecee;margin-bottom:20px;} > > > #ygrp-sponsor #ov ul{ > > > padding:0 0 0 8px;margin:0;} > > > #ygrp-sponsor #ov li{ > > > list-style-type:square;padding:6px 0;font-size:77%;} > > > #ygrp-sponsor #ov li a{ > > > text-decoration:none;font-size:130%;} > > > #ygrp-sponsor #nc{ > > > background-color:#eee;margin-bottom:20px;padding:0 8px;} > > > #ygrp-sponsor .ad{ > > > padding:8px 0;} > > > #ygrp-sponsor .ad #hd1{ > > > font-family:Arial;font-weight:bold;color:#628c2a;font- > > size:100%;line-height:122%;} > > > #ygrp-sponsor .ad a{ > > > text-decoration:none;} > > > #ygrp-sponsor .ad a:hover{ > > > text-decoration:underline;} > > > #ygrp-sponsor .ad p{ > > > margin:0;} > > > o{font-size:0;} > > > .MsoNormal{ > > > margin:0 0 0 0;} > > > #ygrp-text tt{ > > > font-size:120%;} > > > blockquote{margin:0 0 0 4px;} > > > .replbq{margin:4;} > > > --> > > > > > > > > > > > > > > > > > > > > > > > > > > > > > ______________________________________________________________________ > > ______________ > > > Looking for last minute shopping deals? > > > Find them fast with Yahoo! Search. > > http://tools.search.yahoo.com/newsearch/category.php? category=shopping > > > > > > Quote Link to comment Share on other sites More sharing options...
Guest guest Posted December 30, 2007 Report Share Posted December 30, 2007 bruce, i have a queson for you Is there a difference between ild and nsip? also with gerd my lower spinchter is messed up and my grade is a b or 2 stage. what do you all find to ease acid reflux from comming back up? di nsip 02 i realize reading your post you are up on everything i admire your writing. di nsip 202Bruce Moreland wrote: Very interesting article. What I find interesting too is that with the inconsistency I'll bet lots of those pulmonologists are still adamant over their way. At least mine said, some believe this and some believe that and talked about the options although not sure he understood my choices. Well, my pulmonologist probably believes I'm a pain. My PCP knows I am but he shows me respect because he knows how many times when I've felt there was a problem there turned out to be one. He didn't believe (and he basically admitted it later by not disagreeing when I said it) that I had a problem beyond being out of shape, but he still humored me and took precautions and checked. It just took one six minute walk and he realized I was right, that there was something else wrong.Schools here are increasing courses on talking and listening to patients and encouraging doctors to take continuing credit courses in the area, recognizing how much failing to do so well impacts their treatment. > > >> > > Thanks ,> > > That was really informative and for me it answered the > > question of why prednisone works for some of us and not for others. > > I thought all forms of PF were inflammatory and didn't realize IPF > > was not. > > > > > > Sarcoid/PF 3/2006 California> > > > > > > > > PF and Raynauds Disease> > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > Long post here folks bear with me.> > > > > > > > > > > > Raynauds Syndrome is a vasospasmic disorder which affects between 5%> > > > > > to 10% of the US population. About 20% of women in their child > > bearing> > > > > > years are afflicted. The disorder is more common among women than > > men.> > > > > > > > > > > > There are two forms of the disease: > > > > > > > > > > > > Primary Raynauds is the most common form of the disease and usually > > is> > > > > > of earlier onset. It is called Raynauds Disease (RD). It is of > > unknown> > > > > > etiology. > > > > > > > > > > > > Secondary Raynauds is called Raynauds Phenomenon (RP). It is> > > > > > considered to be the more serious of the two and its onset is later > > in> > > > > > life (third decade and out). RP like many forms of PF is considered > > an> > > > > > inflammatory condition. Many forms of Pulmonary Fibrosis (PF), like > > RP> > > > > > , are co-morbid or secondary diseases. > > > > > > > > > > > > Known causes of both RP and/or PF are:> > > > > > > > > > > > Collagen Vascular Disease, Connective Tissue Disease, Rheumatic> > > > > > Disease, Atherosclerosis, Auto-Immune Disease, Repetitive Stress> > > > > > Injuries, Trauma, Smoking, Medication and Chemotherapy exposure,> > > > > > Chemical exposure and, some Endocrine and Hormonal disorders.> > > > > > > > > > > > It is quite possible that many of us on this Board suffer from RP > > and> > > > > > PF AND a PRIMARY co-morbid (co-existing) diagnosis. > > > > > > > > > > > > Last,in that UIP/IPF (usual interstitial pneumonitis / idiopathic> > > > > > pulmonary fibrosis)is NOT considered to be an inflammatory form of > > PF> > > > > > and, is of unknown etiology it follows that if you suffer from > > UIP/IPF> > > > > > and Raynauds it is more likely to be the less serious of the two RD> > > > > > and not RP.> > > > > > > > > > > > For me, my DX (5.06)is Usual Interstial Pneumonitis and Langerhans> > > > > > Cell Histiocytosis. I have had Raynauds Disease all my life. I find > > RD> > > > > > to be distracting and inconvenient but never anything more than > > that.> > > > > > > > > > > > UIP/LCH 5.06 CA> > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > <!--> > > > > > #ygrp-mkp{> > > border:1px solid #d8d8d8;font-family:Arial;margin:14px > > 0px;padding:0px 14px;}> > > #ygrp-mkp hr{> > > border:1px solid #d8d8d8;}> > > #ygrp-mkp #hd{> > > color:#628c2a;font-size:85%;font-weight:bold;line-> > height:122%;margin:10px 0px;}> > > #ygrp-mkp #ads{> > > margin-bottom:10px;}> > > #ygrp-mkp .ad{> > > padding:0 0;}> > > #ygrp-mkp .ad a{> > > color:#0000ff;text-decoration:none;}> > > -->> > > > > > > > > > > > <!--> > > > > > #ygrp-sponsor #ygrp-lc{> > > font-family:Arial;}> > > #ygrp-sponsor #ygrp-lc #hd{> > > margin:10px 0px;font-weight:bold;font-size:78%;line-height:122%;}> > > #ygrp-sponsor #ygrp-lc .ad{> > > margin-bottom:10px;padding:0 0;}> > > -->> > > > > > > > > > > > <!--> > > > > > #ygrp-mlmsg {font-size:13px;font-family:arial, helvetica, clean, > > sans-serif;}> > > #ygrp-mlmsg table {font-size:inherit;font:100%;}> > > #ygrp-mlmsg select, input, textarea {font:99% arial, helvetica, > > clean, sans-serif;}> > > #ygrp-mlmsg pre, code {font:115% monospace;}> > > #ygrp-mlmsg * {line-height:1.22em;}> > > #ygrp-text{> > > font-family:Georgia;> > > }> > > #ygrp-text p{> > > margin:0 0 1em 0;}> > > #ygrp-tpmsgs{> > > font-family:Arial;> > > clear:both;}> > > #ygrp-vitnav{> > > padding-top:10px;font-family:Verdana;font-size:77%;margin:0;}> > > #ygrp-vitnav a{> > > padding:0 1px;}> > > #ygrp-actbar{> > > clear:both;margin:25px 0;white-space:nowrap;color:#666;text-> > align:right;}> > > #ygrp-actbar .left{> > > float:left;white-space:nowrap;}> > > .bld{font-weight:bold;}> > > #ygrp-grft{> > > font-family:Verdana;font-size:77%;padding:15px 0;}> > > #ygrp-ft{> > > font-family:verdana;font-size:77%;border-top:1px solid #666;> > > padding:5px 0;> > > }> > > #ygrp-mlmsg #logo{> > > padding-bottom:10px;}> > > > > > #ygrp-vital{> > > background-color:#e0ecee;margin-bottom:20px;padding:2px 0 8px 8px;}> > > #ygrp-vital #vithd{> > > font-size:77%;font-family:Verdana;font-weight:bold;color:#333;text-> > transform:uppercase;}> > > #ygrp-vital ul{> > > padding:0;margin:2px 0;}> > > #ygrp-vital ul li{> > > list-style-type:none;clear:both;border:1px solid #e0ecee;> > > }> > > #ygrp-vital ul li .ct{> > > font-weight:bold;color:#ff7900;float:right;width:2em;text-> > align:right;padding-right:.5em;}> > > #ygrp-vital ul li .cat{> > > font-weight:bold;}> > > #ygrp-vital a{> > > text-decoration:none;}> > > > > > #ygrp-vital a:hover{> > > text-decoration:underline;}> > > > > > #ygrp-sponsor #hd{> > > color:#999;font-size:77%;}> > > #ygrp-sponsor #ov{> > > padding:6px 13px;background-color:#e0ecee;margin-bottom:20px;}> > > #ygrp-sponsor #ov ul{> > > padding:0 0 0 8px;margin:0;}> > > #ygrp-sponsor #ov li{> > > list-style-type:square;padding:6px 0;font-size:77%;}> > > #ygrp-sponsor #ov li a{> > > text-decoration:none;font-size:130%;}> > > #ygrp-sponsor #nc{> > > background-color:#eee;margin-bottom:20px;padding:0 8px;}> > > #ygrp-sponsor .ad{> > > padding:8px 0;}> > > #ygrp-sponsor .ad #hd1{> > > font-family:Arial;font-weight:bold;color:#628c2a;font-> > size:100%;line-height:122%;}> > > #ygrp-sponsor .ad a{> > > text-decoration:none;}> > > #ygrp-sponsor .ad a:hover{> > > text-decoration:underline;}> > > #ygrp-sponsor .ad p{> > > margin:0;}> > > o{font-size:0;}> > > .MsoNormal{> > > margin:0 0 0 0;}> > > #ygrp-text tt{> > > font-size:120%;}> > > blockquote{margin:0 0 0 4px;}> > > .replbq{margin:4;}> > > -->> > > > > > > > > > > > > > > > > > > > > > > > > > > > > __________________________________________________________> > ______________> > > Looking for last minute shopping deals? > > > Find them fast with Yahoo! Search. > > http://tools.search.yahoo.com/newsearch/category.php?category=shopping> > >> >> Never miss a thing. Make Yahoo your homepage. Quote Link to comment Share on other sites More sharing options...
Guest guest Posted December 30, 2007 Report Share Posted December 30, 2007 Hi , While you wait for Bruce's scholarly reply I'll put in my notions since I'm thought to have BOTH UIP and Fibrotic NSIP.....now ILD stands for Interstitial Lung Disease & NSIP is but one of those.....confusion arises because different Pulmos (either in the same country as well as in different countries) use intermingling terms for the whole bang lot. I wish they'd have an International Symposium & sort out the nomenclature once & for all...an International Standard Glossary for Interstital Lung Disease! The other term that get s confused is IPF: Idiopathic Pulmonary Fibrosis. In some places it means the same as UIP (Usual Interstitial Pneumonitis) . Some doctors now use the term IPF ONLY to mean what others call UIP!!!! HOW confusing is that. In Australia IPF is still used as an UMBRELLA TERM. UIP & NSIP, BOOP , & others are used to indicate the SPECIFIC FORMS of IPF.....they are ALL Interstitial Lung Diseases! (ILD's) With NSIP (Non-Specific Interstitial Pneunonitis) there are 2 Forms: Fibrotic & Cellular. Cellular has a much better prognosis than Fibrotic Forms. Cellular NSIP is the one that responds best to Steroids. Fibrotic NSIP is still treated with Steroids but the results are not as clear-cut. Relapse is upwards of 60% according to my Lung Transplant Specialist. It is possible for lungs to have BOTH Fibrotic NSIP AND UIP at the same time although no one has worked out why as yet. When this is the case the UIP seems to 'take over' as the dominant disease process. There are thought to be differences in the way Fibrosis gets started bewteen UIP & NSIP but it IS all still THEORY! Now over to Bruce for the latest.... in Oz IPF: Fibrotic NSIP/UIP?????? Reynauds' May 2006 > > > >> > > > Thanks ,> > > > That was really informative and for me it answered the > > > question of why prednisone works for some of us and not for > others. > > > I thought all forms of PF were inflammatory and didn't realize > IPF > > > was not. > > > > > > > > Sarcoid/PF 3/2006 California> > > > > > > > > > > > PF and Raynauds Disease> > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > Long post here folks bear with me.> > > > > > > > > > > > > > > > Raynauds Syndrome is a vasospasmic disorder which affects > between 5%> > > > > > > > to 10% of the US population. About 20% of women in their child > > > bearing> > > > > > > > years are afflicted. The disorder is more common among women > than > > > men.> > > > > > > > > > > > > > > > There are two forms of the disease: > > > > > > > > > > > > > > > > Primary Raynauds is the most common form of the disease and > usually > > > is> > > > > > > > of earlier onset. It is called Raynauds Disease (RD). It is of > > > unknown> > > > > > > > etiology. > > > > > > > > > > > > > > > > Secondary Raynauds is called Raynauds Phenomenon (RP). It is> > > > > > > > considered to be the more serious of the two and its onset is > later > > > in> > > > > > > > life (third decade and out). RP like many forms of PF is > considered > > > an> > > > > > > > inflammatory condition. Many forms of Pulmonary Fibrosis (PF), > like > > > RP> > > > > > > > , are co-morbid or secondary diseases. > > > > > > > > > > > > > > > > Known causes of both RP and/or PF are:> > > > > > > > > > > > > > > > Collagen Vascular Disease, Connective Tissue Disease, Rheumatic> > > > > > > > Disease, Atherosclerosis, Auto-Immune Disease, Repetitive Stress> > > > > > > > Injuries, Trauma, Smoking, Medication and Chemotherapy exposure,> > > > > > > > Chemical exposure and, some Endocrine and Hormonal disorders.> > > > > > > > > > > > > > > > It is quite possible that many of us on this Board suffer from > RP > > > and> > > > > > > > PF AND a PRIMARY co-morbid (co-existing) diagnosis. > > > > > > > > > > > > > > > > Last,in that UIP/IPF (usual interstitial pneumonitis / > idiopathic> > > > > > > > pulmonary fibrosis)is NOT considered to be an inflammatory form > of > > > PF> > > > > > > > and, is of unknown etiology it follows that if you suffer from > > > UIP/IPF> > > > > > > > and Raynauds it is more likely to be the less serious of the > two RD> > > > > > > > and not RP.> > > > > > > > > > > > > > > > For me, my DX (5.06)is Usual Interstial Pneumonitis and > Langerhans> > > > > > > > Cell Histiocytosis. I have had Raynauds Disease all my life. I > find > > > RD> > > > > > > > to be distracting and inconvenient but never anything more than > > > that.> > > > > > > > > > > > > > > > UIP/LCH 5.06 CA> > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > <!--> > > > > > > > #ygrp-mkp{> > > > border:1px solid #d8d8d8;font-family:Arial;margin:14px > > > 0px;padding:0px 14px;}> > > > #ygrp-mkp hr{> > > > border:1px solid #d8d8d8;}> > > > #ygrp-mkp #hd{> > > > color:#628c2a;font-size:85%;font-weight:bold;line-> > > height:122%;margin:10px 0px;}> > > > #ygrp-mkp #ads{> > > > margin-bottom:10px;}> > > > #ygrp-mkp .ad{> > > > padding:0 0;}> > > > #ygrp-mkp .ad a{> > > > color:#0000ff;text-decoration:none;}> > > > -->> > > > > > > > > > > > > > > > <!--> > > > > > > > #ygrp-sponsor #ygrp-lc{> > > > font-family:Arial;}> > > > #ygrp-sponsor #ygrp-lc #hd{> > > > margin:10px 0px;font-weight:bold;font-size:78%;line-> height:122%;}> > > > #ygrp-sponsor #ygrp-lc .ad{> > > > margin-bottom:10px;padding:0 0;}> > > > -->> > > > > > > > > > > > > > > > <!--> > > > > > > > #ygrp-mlmsg {font-size:13px;font-family:arial, helvetica, > clean, > > > sans-serif;}> > > > #ygrp-mlmsg table {font-size:inherit;font:100%;}> > > > #ygrp-mlmsg select, input, textarea {font:99% arial, helvetica, > > > clean, sans-serif;}> > > > #ygrp-mlmsg pre, code {font:115% monospace;}> > > > #ygrp-mlmsg * {line-height:1.22em;}> > > > #ygrp-text{> > > > font-family:Georgia;> > > > }> > > > #ygrp-text p{> > > > margin:0 0 1em 0;}> > > > #ygrp-tpmsgs{> > > > font-family:Arial;> > > > clear:both;}> > > > #ygrp-vitnav{> > > > padding-top:10px;font-family:Verdana;font-size:77%;margin:0;}> > > > #ygrp-vitnav a{> > > > padding:0 1px;}> > > > #ygrp-actbar{> > > > clear:both;margin:25px 0;white-space:nowrap;color:#666;text-> > > align:right;}> > > > #ygrp-actbar .left{> > > > float:left;white-space:nowrap;}> > > > .bld{font-weight:bold;}> > > > #ygrp-grft{> > > > font-family:Verdana;font-size:77%;padding:15px 0;}> > > > #ygrp-ft{> > > > font-family:verdana;font-size:77%;border-top:1px solid #666;> > > > padding:5px 0;> > > > }> > > > #ygrp-mlmsg #logo{> > > > padding-bottom:10px;}> > > > > > > > #ygrp-vital{> > > > background-color:#e0ecee;margin-bottom:20px;padding:2px 0 8px > 8px;}> > > > #ygrp-vital #vithd{> > > > font-size:77%;font-family:Verdana;font-> weight:bold;color:#333;text-> > > transform:uppercase;}> > > > #ygrp-vital ul{> > > > padding:0;margin:2px 0;}> > > > #ygrp-vital ul li{> > > > list-style-type:none;clear:both;border:1px solid #e0ecee;> > > > }> > > > #ygrp-vital ul li .ct{> > > > font-weight:bold;color:#ff7900;float:right;width:2em;text-> > > align:right;padding-right:.5em;}> > > > #ygrp-vital ul li .cat{> > > > font-weight:bold;}> > > > #ygrp-vital a{> > > > text-decoration:none;}> > > > > > > > #ygrp-vital a:hover{> > > > text-decoration:underline;}> > > > > > > > #ygrp-sponsor #hd{> > > > color:#999;font-size:77%;}> > > > #ygrp-sponsor #ov{> > > > padding:6px 13px;background-color:#e0ecee;margin-bottom:20px;}> > > > #ygrp-sponsor #ov ul{> > > > padding:0 0 0 8px;margin:0;}> > > > #ygrp-sponsor #ov li{> > > > list-style-type:square;padding:6px 0;font-size:77%;}> > > > #ygrp-sponsor #ov li a{> > > > text-decoration:none;font-size:130%;}> > > > #ygrp-sponsor #nc{> > > > background-color:#eee;margin-bottom:20px;padding:0 8px;}> > > > #ygrp-sponsor .ad{> > > > padding:8px 0;}> > > > #ygrp-sponsor .ad #hd1{> > > > font-family:Arial;font-weight:bold;color:#628c2a;font-> > > size:100%;line-height:122%;}> > > > #ygrp-sponsor .ad a{> > > > text-decoration:none;}> > > > #ygrp-sponsor .ad a:hover{> > > > text-decoration:underline;}> > > > #ygrp-sponsor .ad p{> > > > margin:0;}> > > > o{font-size:0;}> > > > .MsoNormal{> > > > margin:0 0 0 0;}> > > > #ygrp-text tt{> > > > font-size:120%;}> > > > blockquote{margin:0 0 0 4px;}> > > > .replbq{margin:4;}> > > > -->> > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > __________________________________________________________> > > ______________> > > > Looking for last minute shopping deals? > > > > Find them fast with Yahoo! Search. > > > http://tools.search.yahoo.com/newsearch/category.php?> category=shopping> > > >> > >> >> > > > > > > ---------------------------------> Never miss a thing. Make Yahoo your homepage.> Quote Link to comment Share on other sites More sharing options...
Guest guest Posted December 30, 2007 Report Share Posted December 30, 2007 ILD is Intersitial Lung Disease and and PF is Pulmonary Fibrosis so basically the same. Among those there are over 200 specific diseases. NSIP is one. It is Non-specific interstitial pneumonia and is the second most common form behind IPF (Idiopathic Pulmonary Fibrosis). It does have a better general outlook in terms of lifespan and also does seem to respond more often and better to medications. As to the GERD, weakness of the lower sphincter is common. I have the same as the acid has damaged it. Now that makes the reduction of acid through medications even more critical because the lower sphincter lacks the strength to keep it from rising. You need the meds to protect your esophagus and lungs. As to the esophagus, one thing that does need to be watched carefully for is Barrett's Syndrome. It is not a serious problem itself but it often a precursor to cancer. So, you need to do everything you can to protect your esophagus and lungs, including meds, raising the head of your bed, whatever it takes. You can't undo anything but just fight to keep it from worsening. As to the stages of GERD, I rarely hear them referred to but here is what I found: The first stage is simply excess burping. As you digest your food, gases start to build up. If any of the gases escape through your lower esophageal sphincter they can result in excess burping which can seem innocuous enough but can lead to the more common stage 2. The second stage of acid reflux symptoms is what you hear about more commonly. It is a severe burning sensation in the chest (specifically the breast bone region). It is due to the stomach acids escaping the stomach, passing the lower esophageal sphincter and moving up to the chest region. Because this liquid is very acidic, it can create some very severe pain. Many people even mistakenly believe they are having a heart attack when they are struck with this acid reflux symptom. The third stage is a sore throat. Most people assume that all there is to acid reflux is stage 2. In actual fact, the stomach acid can pass up into the throat doing damage (sometimes permanent) to the throat. The affected person may believe that the sore throat is actually caused from something else, further clouding the issue. The last stage of acid reflux symptoms is a sour taste or even a severely sore mouth. Similar to stage 3, the acid actually makes its way all the way up to the person's mouth again causing damage which can become permanent. Now just because stage 4 happens sometimes doesn't mean thats where you are at all times. And you can be reduced from it back to stage 2 often. However, with any the key is removing the acid. It can be treated more than the reflux itself. > > > > > > > > Thanks , > > > > That was really informative and for me it answered the > > > question of why prednisone works for some of us and not for > others. > > > I thought all forms of PF were inflammatory and didn't realize > IPF > > > was not. > > > > > > > > Sarcoid/PF 3/2006 California > > > > > > > > > > > > PF and Raynauds Disease > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > Long post here folks bear with me. > > > > > > > > > > > > > > > > Raynauds Syndrome is a vasospasmic disorder which affects > between 5% > > > > > > > > to 10% of the US population. About 20% of women in their child > > > bearing > > > > > > > > years are afflicted. The disorder is more common among women > than > > > men. > > > > > > > > > > > > > > > > There are two forms of the disease: > > > > > > > > > > > > > > > > Primary Raynauds is the most common form of the disease and > usually > > > is > > > > > > > > of earlier onset. It is called Raynauds Disease (RD). It is of > > > unknown > > > > > > > > etiology. > > > > > > > > > > > > > > > > Secondary Raynauds is called Raynauds Phenomenon (RP). It is > > > > > > > > considered to be the more serious of the two and its onset is > later > > > in > > > > > > > > life (third decade and out). RP like many forms of PF is > considered > > > an > > > > > > > > inflammatory condition. Many forms of Pulmonary Fibrosis (PF), > like > > > RP > > > > > > > > , are co-morbid or secondary diseases. > > > > > > > > > > > > > > > > Known causes of both RP and/or PF are: > > > > > > > > > > > > > > > > Collagen Vascular Disease, Connective Tissue Disease, Rheumatic > > > > > > > > Disease, Atherosclerosis, Auto-Immune Disease, Repetitive Stress > > > > > > > > Injuries, Trauma, Smoking, Medication and Chemotherapy exposure, > > > > > > > > Chemical exposure and, some Endocrine and Hormonal disorders. > > > > > > > > > > > > > > > > It is quite possible that many of us on this Board suffer from > RP > > > and > > > > > > > > PF AND a PRIMARY co-morbid (co-existing) diagnosis. > > > > > > > > > > > > > > > > Last,in that UIP/IPF (usual interstitial pneumonitis / > idiopathic > > > > > > > > pulmonary fibrosis)is NOT considered to be an inflammatory form > of > > > PF > > > > > > > > and, is of unknown etiology it follows that if you suffer from > > > UIP/IPF > > > > > > > > and Raynauds it is more likely to be the less serious of the > two RD > > > > > > > > and not RP. > > > > > > > > > > > > > > > > For me, my DX (5.06)is Usual Interstial Pneumonitis and > Langerhans > > > > > > > > Cell Histiocytosis. I have had Raynauds Disease all my life. I > find > > > RD > > > > > > > > to be distracting and inconvenient but never anything more than > > > that. > > > > > > > > > > > > > > > > UIP/LCH 5.06 CA > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > <!-- > > > > > > > > #ygrp-mkp{ > > > > border:1px solid #d8d8d8;font-family:Arial;margin:14px > > > 0px;padding:0px 14px;} > > > > #ygrp-mkp hr{ > > > > border:1px solid #d8d8d8;} > > > > #ygrp-mkp #hd{ > > > > color:#628c2a;font-size:85%;font-weight:bold;line- > > > height:122%;margin:10px 0px;} > > > > #ygrp-mkp #ads{ > > > > margin-bottom:10px;} > > > > #ygrp-mkp .ad{ > > > > padding:0 0;} > > > > #ygrp-mkp .ad a{ > > > > color:#0000ff;text-decoration:none;} > > > > --> > > > > > > > > > > > > > > > > <!-- > > > > > > > > #ygrp-sponsor #ygrp-lc{ > > > > font-family:Arial;} > > > > #ygrp-sponsor #ygrp-lc #hd{ > > > > margin:10px 0px;font-weight:bold;font-size:78%;line- > height:122%;} > > > > #ygrp-sponsor #ygrp-lc .ad{ > > > > margin-bottom:10px;padding:0 0;} > > > > --> > > > > > > > > > > > > > > > > <!-- > > > > > > > > #ygrp-mlmsg {font-size:13px;font-family:arial, helvetica, > clean, > > > sans-serif;} > > > > #ygrp-mlmsg table {font-size:inherit;font:100%;} > > > > #ygrp-mlmsg select, input, textarea {font:99% arial, helvetica, > > > clean, sans-serif;} > > > > #ygrp-mlmsg pre, code {font:115% monospace;} > > > > #ygrp-mlmsg * {line-height:1.22em;} > > > > #ygrp-text{ > > > > font-family:Georgia; > > > > } > > > > #ygrp-text p{ > > > > margin:0 0 1em 0;} > > > > #ygrp-tpmsgs{ > > > > font-family:Arial; > > > > clear:both;} > > > > #ygrp-vitnav{ > > > > padding-top:10px;font-family:Verdana;font-size:77%;margin:0;} > > > > #ygrp-vitnav a{ > > > > padding:0 1px;} > > > > #ygrp-actbar{ > > > > clear:both;margin:25px 0;white-space:nowrap;color:#666;text- > > > align:right;} > > > > #ygrp-actbar .left{ > > > > float:left;white-space:nowrap;} > > > > .bld{font-weight:bold;} > > > > #ygrp-grft{ > > > > font-family:Verdana;font-size:77%;padding:15px 0;} > > > > #ygrp-ft{ > > > > font-family:verdana;font-size:77%;border-top:1px solid #666; > > > > padding:5px 0; > > > > } > > > > #ygrp-mlmsg #logo{ > > > > padding-bottom:10px;} > > > > > > > > #ygrp-vital{ > > > > background-color:#e0ecee;margin-bottom:20px;padding:2px 0 8px > 8px;} > > > > #ygrp-vital #vithd{ > > > > font-size:77%;font-family:Verdana;font- > weight:bold;color:#333;text- > > > transform:uppercase;} > > > > #ygrp-vital ul{ > > > > padding:0;margin:2px 0;} > > > > #ygrp-vital ul li{ > > > > list-style-type:none;clear:both;border:1px solid #e0ecee; > > > > } > > > > #ygrp-vital ul li .ct{ > > > > font-weight:bold;color:#ff7900;float:right;width:2em;text- > > > align:right;padding-right:.5em;} > > > > #ygrp-vital ul li .cat{ > > > > font-weight:bold;} > > > > #ygrp-vital a{ > > > > text-decoration:none;} > > > > > > > > #ygrp-vital a:hover{ > > > > text-decoration:underline;} > > > > > > > > #ygrp-sponsor #hd{ > > > > color:#999;font-size:77%;} > > > > #ygrp-sponsor #ov{ > > > > padding:6px 13px;background-color:#e0ecee;margin-bottom:20px;} > > > > #ygrp-sponsor #ov ul{ > > > > padding:0 0 0 8px;margin:0;} > > > > #ygrp-sponsor #ov li{ > > > > list-style-type:square;padding:6px 0;font-size:77%;} > > > > #ygrp-sponsor #ov li a{ > > > > text-decoration:none;font-size:130%;} > > > > #ygrp-sponsor #nc{ > > > > background-color:#eee;margin-bottom:20px;padding:0 8px;} > > > > #ygrp-sponsor .ad{ > > > > padding:8px 0;} > > > > #ygrp-sponsor .ad #hd1{ > > > > font-family:Arial;font-weight:bold;color:#628c2a;font- > > > size:100%;line-height:122%;} > > > > #ygrp-sponsor .ad a{ > > > > text-decoration:none;} > > > > #ygrp-sponsor .ad a:hover{ > > > > text-decoration:underline;} > > > > #ygrp-sponsor .ad p{ > > > > margin:0;} > > > > o{font-size:0;} > > > > .MsoNormal{ > > > > margin:0 0 0 0;} > > > > #ygrp-text tt{ > > > > font-size:120%;} > > > > blockquote{margin:0 0 0 4px;} > > > > .replbq{margin:4;} > > > > --> > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > __________________________________________________________ > > > ______________ > > > > Looking for last minute shopping deals? > > > > Find them fast with Yahoo! Search. > > > http://tools.search.yahoo.com/newsearch/category.php? > category=shopping > > > > > > > > > > > > > > > > --------------------------------- > Never miss a thing. Make Yahoo your homepage. > Quote Link to comment Share on other sites More sharing options...
Guest guest Posted December 30, 2007 Report Share Posted December 30, 2007 bruce thanks that eases my mind a lot that was probably a dmb question but tanks for listening. diBruce Moreland wrote: ILD is Intersitial Lung Disease and and PF is Pulmonary Fibrosis so basically the same. Among those there are over 200 specific diseases. NSIP is one. It is Non-specific interstitial pneumonia and is the second most common form behind IPF (Idiopathic Pulmonary Fibrosis). It does have a better general outlook in terms of lifespan and also does seem to respond more often and better to medications.As to the GERD, weakness of the lower sphincter is common. I have the same as the acid has damaged it. Now that makes the reduction of acid through medications even more critical because the lower sphincter lacks the strength to keep it from rising. You need the meds to protect your esophagus and lungs. As to the esophagus, one thing that does need to be watched carefully for is Barrett's Syndrome. It is not a serious problem itself but it often a precursor to cancer. So, you need to do everything you can to protect your esophagus and lungs, including meds, raising the head of your bed, whatever it takes. You can't undo anything but just fight to keep it from worsening.As to the stages of GERD, I rarely hear them referred to but here is what I found:The first stage is simply excess burping. As you digest your food, gases start to build up. If any of the gases escape through your lower esophageal sphincter they can result in excess burping which can seem innocuous enough but can lead to the more common stage 2.The second stage of acid reflux symptoms is what you hear about more commonly. It is a severe burning sensation in the chest (specifically the breast bone region). It is due to the stomach acids escaping the stomach, passing the lower esophageal sphincter and moving up to the chest region. Because this liquid is very acidic, it can create some very severe pain. Many people even mistakenly believe they are having a heart attack when they are struck with this acid reflux symptom.The third stage is a sore throat. Most people assume that all there is to acid reflux is stage 2. In actual fact, the stomach acid can pass up into the throat doing damage (sometimes permanent) to the throat. The affected person may believe that the sore throat is actually caused from something else, further clouding the issue.The last stage of acid reflux symptoms is a sour taste or even a severely sore mouth. Similar to stage 3, the acid actually makes its way all the way up to the person's mouth again causing damage which can become permanent.Now just because stage 4 happens sometimes doesn't mean thats where you are at all times. And you can be reduced from it back to stage 2 often. However, with any the key is removing the acid. It can be treated more than the reflux itself. > > > >> > > > Thanks ,> > > > That was really informative and for me it answered the > > > question of why prednisone works for some of us and not for > others. > > > I thought all forms of PF were inflammatory and didn't realize > IPF > > > was not. > > > > > > > > Sarcoid/PF 3/2006 California> > > > > > > > > > > > PF and Raynauds Disease> > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > Long post here folks bear with me.> > > > > > > > > > > > > > > > Raynauds Syndrome is a vasospasmic disorder which affects > between 5%> > > > > > > > to 10% of the US population. About 20% of women in their child > > > bearing> > > > > > > > years are afflicted. The disorder is more common among women > than > > > men.> > > > > > > > > > > > > > > > There are two forms of the disease: > > > > > > > > > > > > > > > > Primary Raynauds is the most common form of the disease and > usually > > > is> > > > > > > > of earlier onset. It is called Raynauds Disease (RD). It is of > > > unknown> > > > > > > > etiology. > > > > > > > > > > > > > > > > Secondary Raynauds is called Raynauds Phenomenon (RP). It is> > > > > > > > considered to be the more serious of the two and its onset is > later > > > in> > > > > > > > life (third decade and out). RP like many forms of PF is > considered > > > an> > > > > > > > inflammatory condition. Many forms of Pulmonary Fibrosis (PF), > like > > > RP> > > > > > > > , are co-morbid or secondary diseases. > > > > > > > > > > > > > > > > Known causes of both RP and/or PF are:> > > > > > > > > > > > > > > > Collagen Vascular Disease, Connective Tissue Disease, Rheumatic> > > > > > > > Disease, Atherosclerosis, Auto-Immune Disease, Repetitive Stress> > > > > > > > Injuries, Trauma, Smoking, Medication and Chemotherapy exposure,> > > > > > > > Chemical exposure and, some Endocrine and Hormonal disorders.> > > > > > > > > > > > > > > > It is quite possible that many of us on this Board suffer from > RP > > > and> > > > > > > > PF AND a PRIMARY co-morbid (co-existing) diagnosis. > > > > > > > > > > > > > > > > Last,in that UIP/IPF (usual interstitial pneumonitis / > idiopathic> > > > > > > > pulmonary fibrosis)is NOT considered to be an inflammatory form > of > > > PF> > > > > > > > and, is of unknown etiology it follows that if you suffer from > > > UIP/IPF> > > > > > > > and Raynauds it is more likely to be the less serious of the > two RD> > > > > > > > and not RP.> > > > > > > > > > > > > > > > For me, my DX (5.06)is Usual Interstial Pneumonitis and > Langerhans> > > > > > > > Cell Histiocytosis. I have had Raynauds Disease all my life. I > find > > > RD> > > > > > > > to be distracting and inconvenient but never anything more than > > > that.> > > > > > > > > > > > > > > > UIP/LCH 5.06 CA> > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > <!--> > > > > > > > #ygrp-mkp{> > > > border:1px solid #d8d8d8;font-family:Arial;margin:14px > > > 0px;padding:0px 14px;}> > > > #ygrp-mkp hr{> > > > border:1px solid #d8d8d8;}> > > > #ygrp-mkp #hd{> > > > color:#628c2a;font-size:85%;font-weight:bold;line-> > > height:122%;margin:10px 0px;}> > > > #ygrp-mkp #ads{> > > > margin-bottom:10px;}> > > > #ygrp-mkp .ad{> > > > padding:0 0;}> > > > #ygrp-mkp .ad a{> > > > color:#0000ff;text-decoration:none;}> > > > -->> > > > > > > > > > > > > > > > <!--> > > > > > > > #ygrp-sponsor #ygrp-lc{> > > > font-family:Arial;}> > > > #ygrp-sponsor #ygrp-lc #hd{> > > > margin:10px 0px;font-weight:bold;font-size:78%;line-> height:122%;}> > > > #ygrp-sponsor #ygrp-lc .ad{> > > > margin-bottom:10px;padding:0 0;}> > > > -->> > > > > > > > > > > > > > > > <!--> > > > > > > > #ygrp-mlmsg {font-size:13px;font-family:arial, helvetica, > clean, > > > sans-serif;}> > > > #ygrp-mlmsg table {font-size:inherit;font:100%;}> > > > #ygrp-mlmsg select, input, textarea {font:99% arial, helvetica, > > > clean, sans-serif;}> > > > #ygrp-mlmsg pre, code {font:115% monospace;}> > > > #ygrp-mlmsg * {line-height:1.22em;}> > > > #ygrp-text{> > > > font-family:Georgia;> > > > }> > > > #ygrp-text p{> > > > margin:0 0 1em 0;}> > > > #ygrp-tpmsgs{> > > > font-family:Arial;> > > > clear:both;}> > > > #ygrp-vitnav{> > > > padding-top:10px;font-family:Verdana;font-size:77%;margin:0;}> > > > #ygrp-vitnav a{> > > > padding:0 1px;}> > > > #ygrp-actbar{> > > > clear:both;margin:25px 0;white-space:nowrap;color:#666;text-> > > align:right;}> > > > #ygrp-actbar .left{> > > > float:left;white-space:nowrap;}> > > > .bld{font-weight:bold;}> > > > #ygrp-grft{> > > > font-family:Verdana;font-size:77%;padding:15px 0;}> > > > #ygrp-ft{> > > > font-family:verdana;font-size:77%;border-top:1px solid #666;> > > > padding:5px 0;> > > > }> > > > #ygrp-mlmsg #logo{> > > > padding-bottom:10px;}> > > > > > > > #ygrp-vital{> > > > background-color:#e0ecee;margin-bottom:20px;padding:2px 0 8px > 8px;}> > > > #ygrp-vital #vithd{> > > > font-size:77%;font-family:Verdana;font-> weight:bold;color:#333;text-> > > transform:uppercase;}> > > > #ygrp-vital ul{> > > > padding:0;margin:2px 0;}> > > > #ygrp-vital ul li{> > > > list-style-type:none;clear:both;border:1px solid #e0ecee;> > > > }> > > > #ygrp-vital ul li .ct{> > > > font-weight:bold;color:#ff7900;float:right;width:2em;text-> > > align:right;padding-right:.5em;}> > > > #ygrp-vital ul li .cat{> > > > font-weight:bold;}> > > > #ygrp-vital a{> > > > text-decoration:none;}> > > > > > > > #ygrp-vital a:hover{> > > > text-decoration:underline;}> > > > > > > > #ygrp-sponsor #hd{> > > > color:#999;font-size:77%;}> > > > #ygrp-sponsor #ov{> > > > padding:6px 13px;background-color:#e0ecee;margin-bottom:20px;}> > > > #ygrp-sponsor #ov ul{> > > > padding:0 0 0 8px;margin:0;}> > > > #ygrp-sponsor #ov li{> > > > list-style-type:square;padding:6px 0;font-size:77%;}> > > > #ygrp-sponsor #ov li a{> > > > text-decoration:none;font-size:130%;}> > > > #ygrp-sponsor #nc{> > > > background-color:#eee;margin-bottom:20px;padding:0 8px;}> > > > #ygrp-sponsor .ad{> > > > padding:8px 0;}> > > > #ygrp-sponsor .ad #hd1{> > > > font-family:Arial;font-weight:bold;color:#628c2a;font-> > > size:100%;line-height:122%;}> > > > #ygrp-sponsor .ad a{> > > > text-decoration:none;}> > > > #ygrp-sponsor .ad a:hover{> > > > text-decoration:underline;}> > > > #ygrp-sponsor .ad p{> > > > margin:0;}> > > > o{font-size:0;}> > > > .MsoNormal{> > > > margin:0 0 0 0;}> > > > #ygrp-text tt{> > > > font-size:120%;}> > > > blockquote{margin:0 0 0 4px;}> > > > .replbq{margin:4;}> > > > -->> > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > __________________________________________________________> > > ______________> > > > Looking for last minute shopping deals? > > > > Find them fast with Yahoo! Search. > > > http://tools.search.yahoo.com/newsearch/category.php?> category=shopping> > > >> > >> >> > > > > > > ---------------------------------> Never miss a thing. Make Yahoo your homepage.> Looking for last minute shopping deals? Find them fast with Yahoo! Search. Quote Link to comment Share on other sites More sharing options...
Guest guest Posted December 30, 2007 Report Share Posted December 30, 2007 gina as i told bruce thnks for listening i have not ask any questions on this board because i am afraid i will make a fool of myself. di nsip 202 wrote: Hi , While you wait for Bruce's scholarly reply I'll put in my notions since I'm thought to have BOTH UIP and Fibrotic NSIP.....now ILD stands for Interstitial Lung Disease & NSIP is but one of those.....confusion arises because different Pulmos (either in the same country as well as in different countries) use intermingling terms for the whole bang lot. I wish they'd have an International Symposium & sort out the nomenclature once & for all...an International Standard Glossary for Interstital Lung Disease! The other term that get s confused is IPF: Idiopathic Pulmonary Fibrosis. In some places it means the same as UIP (Usual Interstitial Pneumonitis) . Some doctors now use the term IPF ONLY to mean what others call UIP!!!! HOW confusing is that. In Australia IPF is still used as an UMBRELLA TERM. UIP & NSIP, BOOP , & others are used to indicate the SPECIFIC FORMS of IPF.....they are ALL Interstitial Lung Diseases! (ILD's) With NSIP (Non-Specific Interstitial Pneunonitis) there are 2 Forms: Fibrotic & Cellular. Cellular has a much better prognosis than Fibrotic Forms. Cellular NSIP is the one that responds best to Steroids. Fibrotic NSIP is still treated with Steroids but the results are not as clear-cut. Relapse is upwards of 60% according to my Lung Transplant Specialist. It is possible for lungs to have BOTH Fibrotic NSIP AND UIP at the same time although no one has worked out why as yet. When this is the case the UIP seems to 'take over' as the dominant disease process. There are thought to be differences in the way Fibrosis gets started bewteen UIP & NSIP but it IS all still THEORY! Now over to Bruce for the latest.... in Oz IPF: Fibrotic NSIP/UIP?????? Reynauds' May 2006 > > > >> > > > Thanks ,> > > > That was really informative and for me it answered the > > > question of why prednisone works for some of us and not for > others. > > > I thought all forms of PF were inflammatory and didn't realize > IPF > > > was not. > > > > > > > > Sarcoid/PF 3/2006 California> > > > > > > > > > > > PF and Raynauds Disease> > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > Long post here folks bear with me.> > > > > > > > > > > > > > > > Raynauds Syndrome is a vasospasmic disorder which affects > between 5%> > > > > > > > to 10% of the US population. About 20% of women in their child > > > bearing> > > > > > > > years are afflicted. The disorder is more common among women > than > > > men.> > > > > > > > > > > > > > > > There are two forms of the disease: > > > > > > > > > > > > > > > > Primary Raynauds is the most common form of the disease and > usually > > > is> > > > > > > > of earlier onset. It is called Raynauds Disease (RD). It is of > > > unknown> > > > > > > > etiology. > > > > > > > > > > > > > > > > Secondary Raynauds is called Raynauds Phenomenon (RP). It is> > > > > > > > considered to be the more serious of the two and its onset is > later > > > in> > > > > > > > life (third decade and out). RP like many forms of PF is > considered > > > an> > > > > > > > inflammatory condition. Many forms of Pulmonary Fibrosis (PF), > like > > > RP> > > > > > > > , are co-morbid or secondary diseases. > > > > > > > > > > > > > > > > Known causes of both RP and/or PF are:> > > > > > > > > > > > > > > > Collagen Vascular Disease, Connective Tissue Disease, Rheumatic> > > > > > > > Disease, Atherosclerosis, Auto-Immune Disease, Repetitive Stress> > > > > > > > Injuries, Trauma, Smoking, Medication and Chemotherapy exposure,> > > > > > > > Chemical exposure and, some Endocrine and Hormonal disorders.> > > > > > > > > > > > > > > > It is quite possible that many of us on this Board suffer from > RP > > > and> > > > > > > > PF AND a PRIMARY co-morbid (co-existing) diagnosis. > > > > > > > > > > > > > > > > Last,in that UIP/IPF (usual interstitial pneumonitis / > idiopathic> > > > > > > > pulmonary fibrosis)is NOT considered to be an inflammatory form > of > > > PF> > > > > > > > and, is of unknown etiology it follows that if you suffer from > > > UIP/IPF> > > > > > > > and Raynauds it is more likely to be the less serious of the > two RD> > > > > > > > and not RP.> > > > > > > > > > > > > > > > For me, my DX (5.06)is Usual Interstial Pneumonitis and > Langerhans> > > > > > > > Cell Histiocytosis. I have had Raynauds Disease all my life. I > find > > > RD> > > > > > > > to be distracting and inconvenient but never anything more than > > > that.> > > > > > > > > > > > > > > > UIP/LCH 5.06 CA> > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > <!--> > > > > > > > #ygrp-mkp{> > > > border:1px solid #d8d8d8;font-family:Arial;margin:14px > > > 0px;padding:0px 14px;}> > > > #ygrp-mkp hr{> > > > border:1px solid #d8d8d8;}> > > > #ygrp-mkp #hd{> > > > color:#628c2a;font-size:85%;font-weight:bold;line-> > > height:122%;margin:10px 0px;}> > > > #ygrp-mkp #ads{> > > > margin-bottom:10px;}> > > > #ygrp-mkp .ad{> > > > padding:0 0;}> > > > #ygrp-mkp .ad a{> > > > color:#0000ff;text-decoration:none;}> > > > -->> > > > > > > > > > > > > > > > <!--> > > > > > > > #ygrp-sponsor #ygrp-lc{> > > > font-family:Arial;}> > > > #ygrp-sponsor #ygrp-lc #hd{> > > > margin:10px 0px;font-weight:bold;font-size:78%;line-> height:122%;}> > > > #ygrp-sponsor #ygrp-lc .ad{> > > > margin-bottom:10px;padding:0 0;}> > > > -->> > > > > > > > > > > > > > > > <!--> > > > > > > > #ygrp-mlmsg {font-size:13px;font-family:arial, helvetica, > clean, > > > sans-serif;}> > > > #ygrp-mlmsg table {font-size:inherit;font:100%;}> > > > #ygrp-mlmsg select, input, textarea {font:99% arial, helvetica, > > > clean, sans-serif;}> > > > #ygrp-mlmsg pre, code {font:115% monospace;}> > > > #ygrp-mlmsg * {line-height:1.22em;}> > > > #ygrp-text{> > > > font-family:Georgia;> > > > }> > > > #ygrp-text p{> > > > margin:0 0 1em 0;}> > > > #ygrp-tpmsgs{> > > > font-family:Arial;> > > > clear:both;}> > > > #ygrp-vitnav{> > > > padding-top:10px;font-family:Verdana;font-size:77%;margin:0;}> > > > #ygrp-vitnav a{> > > > padding:0 1px;}> > > > #ygrp-actbar{> > > > clear:both;margin:25px 0;white-space:nowrap;color:#666;text-> > > align:right;}> > > > #ygrp-actbar .left{> > > > float:left;white-space:nowrap;}> > > > .bld{font-weight:bold;}> > > > #ygrp-grft{> > > > font-family:Verdana;font-size:77%;padding:15px 0;}> > > > #ygrp-ft{> > > > font-family:verdana;font-size:77%;border-top:1px solid #666;> > > > padding:5px 0;> > > > }> > > > #ygrp-mlmsg #logo{> > > > padding-bottom:10px;}> > > > > > > > #ygrp-vital{> > > > background-color:#e0ecee;margin-bottom:20px;padding:2px 0 8px > 8px;}> > > > #ygrp-vital #vithd{> > > > font-size:77%;font-family:Verdana;font-> weight:bold;color:#333;text-> > > transform:uppercase;}> > > > #ygrp-vital ul{> > > > padding:0;margin:2px 0;}> > > > #ygrp-vital ul li{> > > > list-style-type:none;clear:both;border:1px solid #e0ecee;> > > > }> > > > #ygrp-vital ul li .ct{> > > > font-weight:bold;color:#ff7900;float:right;width:2em;text-> > > align:right;padding-right:.5em;}> > > > #ygrp-vital ul li .cat{> > > > font-weight:bold;}> > > > #ygrp-vital a{> > > > text-decoration:none;}> > > > > > > > #ygrp-vital a:hover{> > > > text-decoration:underline;}> > > > > > > > #ygrp-sponsor #hd{> > > > color:#999;font-size:77%;}> > > > #ygrp-sponsor #ov{> > > > padding:6px 13px;background-color:#e0ecee;margin-bottom:20px;}> > > > #ygrp-sponsor #ov ul{> > > > padding:0 0 0 8px;margin:0;}> > > > #ygrp-sponsor #ov li{> > > > list-style-type:square;padding:6px 0;font-size:77%;}> > > > #ygrp-sponsor #ov li a{> > > > text-decoration:none;font-size:130%;}> > > > #ygrp-sponsor #nc{> > > > background-color:#eee;margin-bottom:20px;padding:0 8px;}> > > > #ygrp-sponsor .ad{> > > > padding:8px 0;}> > > > #ygrp-sponsor .ad #hd1{> > > > font-family:Arial;font-weight:bold;color:#628c2a;font-> > > size:100%;line-height:122%;}> > > > #ygrp-sponsor .ad a{> > > > text-decoration:none;}> > > > #ygrp-sponsor .ad a:hover{> > > > text-decoration:underline;}> > > > #ygrp-sponsor .ad p{> > > > margin:0;}> > > > o{font-size:0;}> > > > .MsoNormal{> > > > margin:0 0 0 0;}> > > > #ygrp-text tt{> > > > font-size:120%;}> > > > blockquote{margin:0 0 0 4px;}> > > > .replbq{margin:4;}> > > > -->> > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > __________________________________________________________> > > ______________> > > > Looking for last minute shopping deals? > > > > Find them fast with Yahoo! Search. > > > http://tools.search.yahoo.com/newsearch/category.php?> category=shopping> > > >> > >> >> > > > > > > ---------------------------------> Never miss a thing. Make Yahoo your homepage.> Looking for last minute shopping deals? Find them fast with Yahoo! Search. Quote Link to comment Share on other sites More sharing options...
Guest guest Posted December 30, 2007 Report Share Posted December 30, 2007 Dear , Have NO fear m'dear it is the FOOL who DOESN"T ask the questions ..for they shall get NO answers!!!!!! in Oz IPF: Fibrotic NSIP/UIP Reynauds' May 2007> > > > >> > > > > Thanks ,> > > > > That was really informative and for me it answered the > > > > question of why prednisone works for some of us and not for > > others. > > > > I thought all forms of PF were inflammatory and didn't realize > > IPF > > > > was not. > > > > > > > > > > Sarcoid/PF 3/2006 California> > > > > > > > > > > > > > > PF and Raynauds Disease> > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > Long post here folks bear with me.> > > > > > > > > > > > > > > > > > > > Raynauds Syndrome is a vasospasmic disorder which affects > > between 5%> > > > > > > > > > to 10% of the US population. About 20% of women in their child > > > > bearing> > > > > > > > > > years are afflicted. The disorder is more common among women > > than > > > > men.> > > > > > > > > > > > > > > > > > > > There are two forms of the disease: > > > > > > > > > > > > > > > > > > > > Primary Raynauds is the most common form of the disease and > > usually > > > > is> > > > > > > > > > of earlier onset. It is called Raynauds Disease (RD). It is of > > > > unknown> > > > > > > > > > etiology. > > > > > > > > > > > > > > > > > > > > Secondary Raynauds is called Raynauds Phenomenon (RP). It is> > > > > > > > > > considered to be the more serious of the two and its onset is > > later > > > > in> > > > > > > > > > life (third decade and out). RP like many forms of PF is > > considered > > > > an> > > > > > > > > > inflammatory condition. Many forms of Pulmonary Fibrosis (PF), > > like > > > > RP> > > > > > > > > > , are co-morbid or secondary diseases. > > > > > > > > > > > > > > > > > > > > Known causes of both RP and/or PF are:> > > > > > > > > > > > > > > > > > > > Collagen Vascular Disease, Connective Tissue Disease, Rheumatic> > > > > > > > > > Disease, Atherosclerosis, Auto-Immune Disease, Repetitive Stress> > > > > > > > > > Injuries, Trauma, Smoking, Medication and Chemotherapy exposure,> > > > > > > > > > Chemical exposure and, some Endocrine and Hormonal disorders.> > > > > > > > > > > > > > > > > > > > It is quite possible that many of us on this Board suffer from > > RP > > > > and> > > > > > > > > > PF AND a PRIMARY co-morbid (co-existing) diagnosis. > > > > > > > > > > > > > > > > > > > > Last,in that UIP/IPF (usual interstitial pneumonitis / > > idiopathic> > > > > > > > > > pulmonary fibrosis)is NOT considered to be an inflammatory form > > of > > > > PF> > > > > > > > > > and, is of unknown etiology it follows that if you suffer from > > > > UIP/IPF> > > > > > > > > > and Raynauds it is more likely to be the less serious of the > > two RD> > > > > > > > > > and not RP.> > > > > > > > > > > > > > > > > > > > For me, my DX (5.06)is Usual Interstial Pneumonitis and > > Langerhans> > > > > > > > > > Cell Histiocytosis. I have had Raynauds Disease all my life. I > > find > > > > RD> > > > > > > > > > to be distracting and inconvenient but never anything more than > > > > that.> > > > > > > > > > > > > > > > > > > > UIP/LCH 5.06 CA> > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > <!--> > > > > > > > > > #ygrp-mkp{> > > > > border:1px solid #d8d8d8;font-family:Arial;margin:14px > > > > 0px;padding:0px 14px;}> > > > > #ygrp-mkp hr{> > > > > border:1px solid #d8d8d8;}> > > > > #ygrp-mkp #hd{> > > > > color:#628c2a;font-size:85%;font-weight:bold;line-> > > > height:122%;margin:10px 0px;}> > > > > #ygrp-mkp #ads{> > > > > margin-bottom:10px;}> > > > > #ygrp-mkp .ad{> > > > > padding:0 0;}> > > > > #ygrp-mkp .ad a{> > > > > color:#0000ff;text-decoration:none;}> > > > > -->> > > > > > > > > > > > > > > > > > > > <!--> > > > > > > > > > #ygrp-sponsor #ygrp-lc{> > > > > font-family:Arial;}> > > > > #ygrp-sponsor #ygrp-lc #hd{> > > > > margin:10px 0px;font-weight:bold;font-size:78%;line-> > height:122%;}> > > > > #ygrp-sponsor #ygrp-lc .ad{> > > > > margin-bottom:10px;padding:0 0;}> > > > > -->> > > > > > > > > > > > > > > > > > > > <!--> > > > > > > > > > #ygrp-mlmsg {font-size:13px;font-family:arial, helvetica, > > clean, > > > > sans-serif;}> > > > > #ygrp-mlmsg table {font-size:inherit;font:100%;}> > > > > #ygrp-mlmsg select, input, textarea {font:99% arial, helvetica, > > > > clean, sans-serif;}> > > > > #ygrp-mlmsg pre, code {font:115% monospace;}> > > > > #ygrp-mlmsg * {line-height:1.22em;}> > > > > #ygrp-text{> > > > > font-family:Georgia;> > > > > }> > > > > #ygrp-text p{> > > > > margin:0 0 1em 0;}> > > > > #ygrp-tpmsgs{> > > > > font-family:Arial;> > > > > clear:both;}> > > > > #ygrp-vitnav{> > > > > padding-top:10px;font-family:Verdana;font-size:77%;margin:0;}> > > > > #ygrp-vitnav a{> > > > > padding:0 1px;}> > > > > #ygrp-actbar{> > > > > clear:both;margin:25px 0;white-space:nowrap;color:#666;text-> > > > align:right;}> > > > > #ygrp-actbar .left{> > > > > float:left;white-space:nowrap;}> > > > > .bld{font-weight:bold;}> > > > > #ygrp-grft{> > > > > font-family:Verdana;font-size:77%;padding:15px 0;}> > > > > #ygrp-ft{> > > > > font-family:verdana;font-size:77%;border-top:1px solid #666;> > > > > padding:5px 0;> > > > > }> > > > > #ygrp-mlmsg #logo{> > > > > padding-bottom:10px;}> > > > > > > > > > #ygrp-vital{> > > > > background-color:#e0ecee;margin-bottom:20px;padding:2px 0 8px > > 8px;}> > > > > #ygrp-vital #vithd{> > > > > font-size:77%;font-family:Verdana;font-> > weight:bold;color:#333;text-> > > > transform:uppercase;}> > > > > #ygrp-vital ul{> > > > > padding:0;margin:2px 0;}> > > > > #ygrp-vital ul li{> > > > > list-style-type:none;clear:both;border:1px solid #e0ecee;> > > > > }> > > > > #ygrp-vital ul li .ct{> > > > > font-weight:bold;color:#ff7900;float:right;width:2em;text-> > > > align:right;padding-right:.5em;}> > > > > #ygrp-vital ul li .cat{> > > > > font-weight:bold;}> > > > > #ygrp-vital a{> > > > > text-decoration:none;}> > > > > > > > > > #ygrp-vital a:hover{> > > > > text-decoration:underline;}> > > > > > > > > > #ygrp-sponsor #hd{> > > > > color:#999;font-size:77%;}> > > > > #ygrp-sponsor #ov{> > > > > padding:6px 13px;background-color:#e0ecee;margin-bottom:20px;}> > > > > #ygrp-sponsor #ov ul{> > > > > padding:0 0 0 8px;margin:0;}> > > > > #ygrp-sponsor #ov li{> > > > > list-style-type:square;padding:6px 0;font-size:77%;}> > > > > #ygrp-sponsor #ov li a{> > > > > text-decoration:none;font-size:130%;}> > > > > #ygrp-sponsor #nc{> > > > > background-color:#eee;margin-bottom:20px;padding:0 8px;}> > > > > #ygrp-sponsor .ad{> > > > > padding:8px 0;}> > > > > #ygrp-sponsor .ad #hd1{> > > > > font-family:Arial;font-weight:bold;color:#628c2a;font-> > > > size:100%;line-height:122%;}> > > > > #ygrp-sponsor .ad a{> > > > > text-decoration:none;}> > > > > #ygrp-sponsor .ad a:hover{> > > > > text-decoration:underline;}> > > > > #ygrp-sponsor .ad p{> > > > > margin:0;}> > > > > o{font-size:0;}> > > > > .MsoNormal{> > > > > margin:0 0 0 0;}> > > > > #ygrp-text tt{> > > > > font-size:120%;}> > > > > blockquote{margin:0 0 0 4px;}> > > > > .replbq{margin:4;}> > > > > -->> > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > __________________________________________________________> > > > ______________> > > > > Looking for last minute shopping deals? > > > > > Find them fast with Yahoo! Search. > > > > http://tools.search.yahoo.com/newsearch/category.php?> > category=shopping> > > > >> > > >> > >> > > > > > > > > > > > > > ---------------------------------> > Never miss a thing. Make Yahoo your homepage.> >> > > > > > > ---------------------------------> Looking for last minute shopping deals? Find them fast with Yahoo! Search.> Quote Link to comment Share on other sites More sharing options...
Guest guest Posted December 30, 2007 Report Share Posted December 30, 2007 Thanks for sending that Link , I found it most interesting. I've just been reading a Paper from Dutch Researchers published in 'The Journal of Nuclear Medicine', albeit from 2005. These people were trying to find a means of PREDICTING success with Predisone using something called Ga Scintigraphy Tests...they failed BUT it was their conclusion that caught my eye: " Pulmonary Ga uptake cannot be used to predict response to corticosteroid treatment OR prognosis in patients with IIP (Idiopathic Interstitial Pneumonia). Apparently, the inflammatory process influenced by treatment with methylprednisolone DOES NOT DETERMINE THE PROGRESSION OF THE DISEASE. This finding supports the hypothesis that although inflammation is present in IPF and NSIP, it is neither the HALLMARK of the disease NOR the major factor determining prognosis." Karin Grijm, Hein J.Verberne, Frans Krouwels, Weller, Henk Jansen & Bresser. Journal of Nuclear Medicine Vol 46 No 9 1421-1426 2005> > >> > > Thanks ,> > > That was really informative and for me it answered the > > question of why prednisone works for some of us and not for others. > > I thought all forms of PF were inflammatory and didn't realize IPF > > was not. > > > > > > Sarcoid/PF 3/2006 California> > > > > > > > > PF and Raynauds Disease> > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > Long post here folks bear with me.> > > > > > > > > > > > Raynauds Syndrome is a vasospasmic disorder which affects between 5%> > > > > > to 10% of the US population. About 20% of women in their child > > bearing> > > > > > years are afflicted. The disorder is more common among women than > > men.> > > > > > > > > > > > There are two forms of the disease: > > > > > > > > > > > > Primary Raynauds is the most common form of the disease and usually > > is> > > > > > of earlier onset. It is called Raynauds Disease (RD). It is of > > unknown> > > > > > etiology. > > > > > > > > > > > > Secondary Raynauds is called Raynauds Phenomenon (RP). It is> > > > > > considered to be the more serious of the two and its onset is later > > in> > > > > > life (third decade and out). RP like many forms of PF is considered > > an> > > > > > inflammatory condition. Many forms of Pulmonary Fibrosis (PF), like > > RP> > > > > > , are co-morbid or secondary diseases. > > > > > > > > > > > > Known causes of both RP and/or PF are:> > > > > > > > > > > > Collagen Vascular Disease, Connective Tissue Disease, Rheumatic> > > > > > Disease, Atherosclerosis, Auto-Immune Disease, Repetitive Stress> > > > > > Injuries, Trauma, Smoking, Medication and Chemotherapy exposure,> > > > > > Chemical exposure and, some Endocrine and Hormonal disorders.> > > > > > > > > > > > It is quite possible that many of us on this Board suffer from RP > > and> > > > > > PF AND a PRIMARY co-morbid (co-existing) diagnosis. > > > > > > > > > > > > Last,in that UIP/IPF (usual interstitial pneumonitis / idiopathic> > > > > > pulmonary fibrosis)is NOT considered to be an inflammatory form of > > PF> > > > > > and, is of unknown etiology it follows that if you suffer from > > UIP/IPF> > > > > > and Raynauds it is more likely to be the less serious of the two RD> > > > > > and not RP.> > > > > > > > > > > > For me, my DX (5.06)is Usual Interstial Pneumonitis and Langerhans> > > > > > Cell Histiocytosis. I have had Raynauds Disease all my life. I find > > RD> > > > > > to be distracting and inconvenient but never anything more than > > that.> > > > > > > > > > > > UIP/LCH 5.06 CA> > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > <!--> > > > > > #ygrp-mkp{> > > border:1px solid #d8d8d8;font-family:Arial;margin:14px > > 0px;padding:0px 14px;}> > > #ygrp-mkp hr{> > > border:1px solid #d8d8d8;}> > > #ygrp-mkp #hd{> > > color:#628c2a;font-size:85%;font-weight:bold;line-> > height:122%;margin:10px 0px;}> > > #ygrp-mkp #ads{> > > margin-bottom:10px;}> > > #ygrp-mkp .ad{> > > padding:0 0;}> > > #ygrp-mkp .ad a{> > > color:#0000ff;text-decoration:none;}> > > -->> > > > > > > > > > > > <!--> > > > > > #ygrp-sponsor #ygrp-lc{> > > font-family:Arial;}> > > #ygrp-sponsor #ygrp-lc #hd{> > > margin:10px 0px;font-weight:bold;font-size:78%;line-height:122%;}> > > #ygrp-sponsor #ygrp-lc .ad{> > > margin-bottom:10px;padding:0 0;}> > > -->> > > > > > > > > > > > <!--> > > > > > #ygrp-mlmsg {font-size:13px;font-family:arial, helvetica, clean, > > sans-serif;}> > > #ygrp-mlmsg table {font-size:inherit;font:100%;}> > > #ygrp-mlmsg select, input, textarea {font:99% arial, helvetica, > > clean, sans-serif;}> > > #ygrp-mlmsg pre, code {font:115% monospace;}> > > #ygrp-mlmsg * {line-height:1.22em;}> > > #ygrp-text{> > > font-family:Georgia;> > > }> > > #ygrp-text p{> > > margin:0 0 1em 0;}> > > #ygrp-tpmsgs{> > > font-family:Arial;> > > clear:both;}> > > #ygrp-vitnav{> > > padding-top:10px;font-family:Verdana;font-size:77%;margin:0;}> > > #ygrp-vitnav a{> > > padding:0 1px;}> > > #ygrp-actbar{> > > clear:both;margin:25px 0;white-space:nowrap;color:#666;text-> > align:right;}> > > #ygrp-actbar .left{> > > float:left;white-space:nowrap;}> > > .bld{font-weight:bold;}> > > #ygrp-grft{> > > font-family:Verdana;font-size:77%;padding:15px 0;}> > > #ygrp-ft{> > > font-family:verdana;font-size:77%;border-top:1px solid #666;> > > padding:5px 0;> > > }> > > #ygrp-mlmsg #logo{> > > padding-bottom:10px;}> > > > > > #ygrp-vital{> > > background-color:#e0ecee;margin-bottom:20px;padding:2px 0 8px 8px;}> > > #ygrp-vital #vithd{> > > font-size:77%;font-family:Verdana;font-weight:bold;color:#333;text-> > transform:uppercase;}> > > #ygrp-vital ul{> > > padding:0;margin:2px 0;}> > > #ygrp-vital ul li{> > > list-style-type:none;clear:both;border:1px solid #e0ecee;> > > }> > > #ygrp-vital ul li .ct{> > > font-weight:bold;color:#ff7900;float:right;width:2em;text-> > align:right;padding-right:.5em;}> > > #ygrp-vital ul li .cat{> > > font-weight:bold;}> > > #ygrp-vital a{> > > text-decoration:none;}> > > > > > #ygrp-vital a:hover{> > > text-decoration:underline;}> > > > > > #ygrp-sponsor #hd{> > > color:#999;font-size:77%;}> > > #ygrp-sponsor #ov{> > > padding:6px 13px;background-color:#e0ecee;margin-bottom:20px;}> > > #ygrp-sponsor #ov ul{> > > padding:0 0 0 8px;margin:0;}> > > #ygrp-sponsor #ov li{> > > list-style-type:square;padding:6px 0;font-size:77%;}> > > #ygrp-sponsor #ov li a{> > > text-decoration:none;font-size:130%;}> > > #ygrp-sponsor #nc{> > > background-color:#eee;margin-bottom:20px;padding:0 8px;}> > > #ygrp-sponsor .ad{> > > padding:8px 0;}> > > #ygrp-sponsor .ad #hd1{> > > font-family:Arial;font-weight:bold;color:#628c2a;font-> > size:100%;line-height:122%;}> > > #ygrp-sponsor .ad a{> > > text-decoration:none;}> > > #ygrp-sponsor .ad a:hover{> > > text-decoration:underline;}> > > #ygrp-sponsor .ad p{> > > margin:0;}> > > o{font-size:0;}> > > .MsoNormal{> > > margin:0 0 0 0;}> > > #ygrp-text tt{> > > font-size:120%;}> > > blockquote{margin:0 0 0 4px;}> > > .replbq{margin:4;}> > > -->> > > > > > > > > > > > > > > > > > > > > > > > > > > > > ______________________________________________________________________> > ______________> > > Looking for last minute shopping deals? > > > Find them fast with Yahoo! Search. > > http://tools.search.yahoo.com/newsearch/category.php?category=shopping> > >> >> Quote Link to comment Share on other sites More sharing options...
Guest guest Posted December 30, 2007 Report Share Posted December 30, 2007 Di, That's what this board is here for. No question is dumb. There is so much to learn about pulmonary fibrosis. Stick with us and ask any and all questions. We're here to help as best as we can. Leanne Cain wrote: gina as i told bruce thnks for listening i have not ask any questions on this board because i am afraid i will make a fool of myself. di nsip 202 <gina.francisbigpond> wrote: Hi , While you wait for Bruce's scholarly reply I'll put in my notions since I'm thought to have BOTH UIP and Fibrotic NSIP.....now ILD stands for Interstitial Lung Disease & NSIP is but one of those.....confusion arises because different Pulmos (either in the same country as well as in different countries) use intermingling terms for the whole bang lot. I wish they'd have an International Symposium & sort out the nomenclature once & for all...an International Standard Glossary for Interstital Lung Disease! The other term that get s confused is IPF: Idiopathic Pulmonary Fibrosis. In some places it means the same as UIP (Usual Interstitial Pneumonitis) . Some doctors now use the term IPF ONLY to mean what others call UIP!!!! HOW confusing is that. In Australia IPF is still used as an UMBRELLA TERM. UIP & NSIP, BOOP , & others are used to indicate the SPECIFIC FORMS of IPF.....they are ALL Interstitial Lung Diseases! (ILD's) With NSIP (Non-Specific Interstitial Pneunonitis) there are 2 Forms: Fibrotic & Cellular. Cellular has a much better prognosis than Fibrotic Forms. Cellular NSIP is the one that responds best to Steroids. Fibrotic NSIP is still treated with Steroids but the results are not as clear-cut. Relapse is upwards of 60% according to my Lung Transplant Specialist. It is possible for lungs to have BOTH Fibrotic NSIP AND UIP at the same time although no one has worked out why as yet. When this is the case the UIP seems to 'take over' as the dominant disease process. There are thought to be differences in the way Fibrosis gets started bewteen UIP & NSIP but it IS all still THEORY! Now over to Bruce for the latest.... in Oz IPF: Fibrotic NSIP/UIP?????? Reynauds' May 2006 > > > >> > > > Thanks ,> > > > That was really informative and for me it answered the > > > question of why prednisone works for some of us and not for > others. > > > I thought all forms of PF were inflammatory and didn't realize > IPF > > > was not. > > > > > > > > Sarcoid/PF 3/2006 California> > > > > > > > > > > > PF and Raynauds Disease> > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > Long post here folks bear with me.> > > > > > > > > > > > > > > > Raynauds Syndrome is a vasospasmic disorder which affects > between 5%> > > > > > > > to 10% of the US population. About 20% of women in their child > > > bearing> > > > > > > > years are afflicted. The disorder is more common among women > than > > > men.> > > > > > > > > > > > > > > > There are two forms of the disease: > > > > > > > > > > > > > > > > Primary Raynauds is the most common form of the disease and > usually > > > is> > > > > > > > of earlier onset. It is called Raynauds Disease (RD). It is of > > > unknown> > > > > > > > etiology. > > > > > > > > > > > > > > > > Secondary Raynauds is called Raynauds Phenomenon (RP). It is> > > > > > > > considered to be the more serious of the two and its onset is > later > > > in> > > > > > > > life (third decade and out). RP like many forms of PF is > considered > > > an> > > > > > > > inflammatory condition. Many forms of Pulmonary Fibrosis (PF), > like > > > RP> > > > > > > > , are co-morbid or secondary diseases. > > > > > > > > > > > > > > > > Known causes of both RP and/or PF are:> > > > > > > > > > > > > > > > Collagen Vascular Disease, Connective Tissue Disease, Rheumatic> > > > > > > > Disease, Atherosclerosis, Auto-Immune Disease, Repetitive Stress> > > > > > > > Injuries, Trauma, Smoking, Medication and Chemotherapy exposure,> > > > > > > > Chemical exposure and, some Endocrine and Hormonal disorders.> > > > > > > > > > > > > > > > It is quite possible that many of us on this Board suffer from > RP > > > and> > > > > > > > PF AND a PRIMARY co-morbid (co-existing) diagnosis. > > > > > > > > > > > > > > > > Last,in that UIP/IPF (usual interstitial pneumonitis / > idiopathic> > > > > > > > pulmonary fibrosis)is NOT considered to be an inflammatory form > of > > > PF> > > > > > > > and, is of unknown etiology it follows that if you suffer from > > > UIP/IPF> > > > > > > > and Raynauds it is more likely to be the less serious of the > two RD> > > > > > > > and not RP.> > > > > > > > > > > > > > > > For me, my DX (5.06)is Usual Interstial Pneumonitis and > Langerhans> > > > > > > > Cell Histiocytosis. I have had Raynauds Disease all my life. I > find > > > RD> > > > > > > > to be distracting and inconvenient but never anything more than > > > that.> > > > > > > > > > > > > > > > UIP/LCH 5.06 CA> > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > <!--> > > > > > > > #ygrp-mkp{> > > > border:1px solid #d8d8d8;font-family:Arial;margin:14px > > > 0px;padding:0px 14px;}> > > > #ygrp-mkp hr{> > > > border:1px solid #d8d8d8;}> > > > #ygrp-mkp #hd{> > > > color:#628c2a;font-size:85%;font-weight:bold;line-> > > height:122%;margin:10px 0px;}> > > > #ygrp-mkp #ads{> > > > margin-bottom:10px;}> > > > #ygrp-mkp .ad{> > > > padding:0 0;}> > > > #ygrp-mkp .ad a{> > > > color:#0000ff;text-decoration:none;}> > > > -->> > > > > > > > > > > > > > > > <!--> > > > > > > > #ygrp-sponsor #ygrp-lc{> > > > font-family:Arial;}> > > > #ygrp-sponsor #ygrp-lc #hd{> > > > margin:10px 0px;font-weight:bold;font-size:78%;line-> height:122%;}> > > > #ygrp-sponsor #ygrp-lc .ad{> > > > margin-bottom:10px;padding:0 0;}> > > > -->> > > > > > > > > > > > > > > > <!--> > > > > > > > #ygrp-mlmsg {font-size:13px;font-family:arial, helvetica, > clean, > > > sans-serif;}> > > > #ygrp-mlmsg table {font-size:inherit;font:100%;}> > > > #ygrp-mlmsg select, input, textarea {font:99% arial, helvetica, > > > clean, sans-serif;}> > > > #ygrp-mlmsg pre, code {font:115% monospace;}> > > > #ygrp-mlmsg * {line-height:1.22em;}> > > > #ygrp-text{> > > > font-family:Georgia;> > > > }> > > > #ygrp-text p{> > > > margin:0 0 1em 0;}> > > > #ygrp-tpmsgs{> > > > font-family:Arial;> > > > clear:both;}> > > > #ygrp-vitnav{> > > > padding-top:10px;font-family:Verdana;font-size:77%;margin:0;}> > > > #ygrp-vitnav a{> > > > padding:0 1px;}> > > > #ygrp-actbar{> > > > clear:both;margin:25px 0;white-space:nowrap;color:#666;text-> > > align:right;}> > > > #ygrp-actbar .left{> > > > float:left;white-space:nowrap;}> > > > .bld{font-weight:bold;}> > > > #ygrp-grft{> > > > font-family:Verdana;font-size:77%;padding:15px 0;}> > > > #ygrp-ft{> > > > font-family:verdana;font-size:77%;border-top:1px solid #666;> > > > padding:5px 0;> > > > }> > > > #ygrp-mlmsg #logo{> > > > padding-bottom:10px;}> > > > > > > > #ygrp-vital{> > > > background-color:#e0ecee;margin-bottom:20px;padding:2px 0 8px > 8px;}> > > > #ygrp-vital #vithd{> > > > font-size:77%;font-family:Verdana;font-> weight:bold;color:#333;text-> > > transform:uppercase;}> > > > #ygrp-vital ul{> > > > padding:0;margin:2px 0;}> > > > #ygrp-vital ul li{> > > > list-style-type:none;clear:both;border:1px solid #e0ecee;> > > > }> > > > #ygrp-vital ul li .ct{> > > > font-weight:bold;color:#ff7900;float:right;width:2em;text-> > > align:right;padding-right:.5em;}> > > > #ygrp-vital ul li .cat{> > > > font-weight:bold;}> > > > #ygrp-vital a{> > > > text-decoration:none;}> > > > > > > > #ygrp-vital a:hover{> > > > text-decoration:underline;}> > > > > > > > #ygrp-sponsor #hd{> > > > color:#999;font-size:77%;}> > > > #ygrp-sponsor #ov{> > > > padding:6px 13px;background-color:#e0ecee;margin-bottom:20px;}> > > > #ygrp-sponsor #ov ul{> > > > padding:0 0 0 8px;margin:0;}> > > > #ygrp-sponsor #ov li{> > > > list-style-type:square;padding:6px 0;font-size:77%;}> > > > #ygrp-sponsor #ov li a{> > > > text-decoration:none;font-size:130%;}> > > > #ygrp-sponsor #nc{> > > > background-color:#eee;margin-bottom:20px;padding:0 8px;}> > > > #ygrp-sponsor .ad{> > > > padding:8px 0;}> > > > #ygrp-sponsor .ad #hd1{> > > > font-family:Arial;font-weight:bold;color:#628c2a;font-> > > size:100%;line-height:122%;}> > > > #ygrp-sponsor .ad a{> > > > text-decoration:none;}> > > > #ygrp-sponsor .ad a:hover{> > > > text-decoration:underline;}> > > > #ygrp-sponsor .ad p{> > > > margin:0;}> > > > o{font-size:0;}> > > > .MsoNormal{> > > > margin:0 0 0 0;}> > > > #ygrp-text tt{> > > > font-size:120%;}> > > > blockquote{margin:0 0 0 4px;}> > > > .replbq{margin:4;}> > > > -->> > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > __________________________________________________________> > > ______________> > > > Looking for last minute shopping deals? > > > > Find them fast with Yahoo! Search. > > > http://tools.search.yahoo.com/newsearch/category.php?> category=shopping> > > >> > >> >> > > > > > > ---------------------------------> Never miss a thing. Make Yahoo your homepage.> Looking for last minute shopping deals? Find them fast with Yahoo! Search. Looking for last minute shopping deals? Find them fast with Yahoo! Search. Quote Link to comment Share on other sites More sharing options...
Guest guest Posted December 30, 2007 Report Share Posted December 30, 2007 , BTW there is no such thing as a dumb question!!! Z fibriotic NSIP/05 Z fibriotic NSIP/o5/PA And “mild” PH/10/07 and Reynaud’s too!! Potter, reader,carousel lover and MomMom to Darah “I’m gonna be iron like a lion in Zion” Bob Marley Cain wrote: bruce thanks that eases my mind a lot that was probably a dmb question but tanks for listening. di Bruce Moreland <brucemorelandgmail> wrote: ILD is Intersitial Lung Disease and and PF is Pulmonary Fibrosis so basically the same. Among those there are over 200 specific diseases. NSIP is one. It is Non-specific interstitial pneumonia and is the second most common form behind IPF (Idiopathic Pulmonary Fibrosis). It does have a better general outlook in terms of lifespan and also does seem to respond more often and better to medications. As to the GERD, weakness of the lower sphincter is common. I have the same as the acid has damaged it. Now that makes the reduction of acid through medications even more critical because the lower sphincter lacks the strength to keep it from rising. You need the meds to protect your esophagus and lungs. As to the esophagus, one thing that does need to be watched carefully for is Barrett's Syndrome. It is not a serious problem itself but it often a precursor to cancer. So, you need to do everything you can to protect your esophagus and lungs, including meds, raising the head of your bed, whatever it takes. You can't undo anything but just fight to keep it from worsening. As to the stages of GERD, I rarely hear them referred to but here is what I found: The first stage is simply excess burping. As you digest your food, gases start to build up. If any of the gases escape through your lower esophageal sphincter they can result in excess burping which can seem innocuous enough but can lead to the more common stage 2. The second stage of acid reflux symptoms is what you hear about more commonly. It is a severe burning sensation in the chest (specifically the breast bone region). It is due to the stomach acids escaping the stomach, passing the lower esophageal sphincter and moving up to the chest region. Because this liquid is very acidic, it can create some very severe pain. Many people even mistakenly believe they are having a heart attack when they are struck with this acid reflux symptom. The third stage is a sore throat. Most people assume that all there is to acid reflux is stage 2. In actual fact, the stomach acid can pass up into the throat doing damage (sometimes permanent) to the throat. The affected person may believe that the sore throat is actually caused from something else, further clouding the issue. The last stage of acid reflux symptoms is a sour taste or even a severely sore mouth. Similar to stage 3, the acid actually makes its way all the way up to the person's mouth again causing damage which can become permanent. Now just because stage 4 happens sometimes doesn't mean thats where you are at all times. And you can be reduced from it back to stage 2 often. However, with any the key is removing the acid. It can be treated more than the reflux itself. > > > > > > > > Thanks , > > > > That was really informative and for me it answered the > > > question of why prednisone works for some of us and not for > others. > > > I thought all forms of PF were inflammatory and didn't realize > IPF > > > was not. > > > > > > > > Sarcoid/PF 3/2006 California > > > > > > > > > > > > PF and Raynauds Disease > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > Long post here folks bear with me. > > > > > > > > > > > > > > > > Raynauds Syndrome is a vasospasmic disorder which affects > between 5% > > > > > > > > to 10% of the US population. About 20% of women in their child > > > bearing > > > > > > > > years are afflicted. The disorder is more common among women > than > > > men. > > > > > > > > > > > > > > > > There are two forms of the disease: > > > > > > > > > > > > > > > > Primary Raynauds is the most common form of the disease and > usually > > > is > > > > > > > > of earlier onset. It is called Raynauds Disease (RD). It is of > > > unknown > > > > > > > > etiology. > > > > > > > > > > > > > > > > Secondary Raynauds is called Raynauds Phenomenon (RP). It is > > > > > > > > considered to be the more serious of the two and its onset is > later > > > in > > > > > > > > life (third decade and out). RP like many forms of PF is > considered > > > an > > > > > > > > inflammatory condition. Many forms of Pulmonary Fibrosis (PF), > like > > > RP > > > > > > > > , are co-morbid or secondary diseases. > > > > > > > > > > > > > > > > Known causes of both RP and/or PF are: > > > > > > > > > > > > > > > > Collagen Vascular Disease, Connective Tissue Disease, Rheumatic > > > > > > > > Disease, Atherosclerosis, Auto-Immune Disease, Repetitive Stress > > > > > > > > Injuries, Trauma, Smoking, Medication and Chemotherapy exposure, > > > > > > > > Chemical exposure and, some Endocrine and Hormonal disorders. > > > > > > > > > > > > > > > > It is quite possible that many of us on this Board suffer from > RP > > > and > > > > > > > > PF AND a PRIMARY co-morbid (co-existing) diagnosis. > > > > > > > > > > > > > > > > Last,in that UIP/IPF (usual interstitial pneumonitis / > idiopathic > > > > > > > > pulmonary fibrosis)is NOT considered to be an inflammatory form > of > > > PF > > > > > > > > and, is of unknown etiology it follows that if you suffer from > > > UIP/IPF > > > > > > > > and Raynauds it is more likely to be the less serious of the > two RD > > > > > > > > and not RP. > > > > > > > > > > > > > > > > For me, my DX (5.06)is Usual Interstial Pneumonitis and > Langerhans > > > > > > > > Cell Histiocytosis. I have had Raynauds Disease all my life. I > find > > > RD > > > > > > > > to be distracting and inconvenient but never anything more than > > > that. > > > > > > > > > > > > > > > > UIP/LCH 5.06 CA > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > <!-- > > > > > > > > #ygrp-mkp{ > > > > border:1px solid #d8d8d8;font-family:Arial;margin:14px > > > 0px;padding:0px 14px;} > > > > #ygrp-mkp hr{ > > > > border:1px solid #d8d8d8;} > > > > #ygrp-mkp #hd{ > > > > color:#628c2a;font-size:85%;font-weight:bold;line- > > > height:122%;margin:10px 0px;} > > > > #ygrp-mkp #ads{ > > > > margin-bottom:10px;} > > > > #ygrp-mkp .ad{ > > > > padding:0 0;} > > > > #ygrp-mkp .ad a{ > > > > color:#0000ff;text-decoration:none;} > > > > --> > > > > > > > > > > > > > > > > <!-- > > > > > > > > #ygrp-sponsor #ygrp-lc{ > > > > font-family:Arial;} > > > > #ygrp-sponsor #ygrp-lc #hd{ > > > > margin:10px 0px;font-weight:bold;font-size:78%;line- > height:122%;} > > > > #ygrp-sponsor #ygrp-lc .ad{ > > > > margin-bottom:10px;padding:0 0;} > > > > --> > > > > > > > > > > > > > > > > <!-- > > > > > > > > #ygrp-mlmsg {font-size:13px;font-family:arial, helvetica, > clean, > > > sans-serif;} > > > > #ygrp-mlmsg table {font-size:inherit;font:100%;} > > > > #ygrp-mlmsg select, input, textarea {font:99% arial, helvetica, > > > clean, sans-serif;} > > > > #ygrp-mlmsg pre, code {font:115% monospace;} > > > > #ygrp-mlmsg * {line-height:1.22em;} > > > > #ygrp-text{ > > > > font-family:Georgia; > > > > } > > > > #ygrp-text p{ > > > > margin:0 0 1em 0;} > > > > #ygrp-tpmsgs{ > > > > font-family:Arial; > > > > clear:both;} > > > > #ygrp-vitnav{ > > > > padding-top:10px;font-family:Verdana;font-size:77%;margin:0;} > > > > #ygrp-vitnav a{ > > > > padding:0 1px;} > > > > #ygrp-actbar{ > > > > clear:both;margin:25px 0;white-space:nowrap;color:#666;text- > > > align:right;} > > > > #ygrp-actbar .left{ > > > > float:left;white-space:nowrap;} > > > > .bld{font-weight:bold;} > > > > #ygrp-grft{ > > > > font-family:Verdana;font-size:77%;padding:15px 0;} > > > > #ygrp-ft{ > > > > font-family:verdana;font-size:77%;border-top:1px solid #666; > > > > padding:5px 0; > > > > } > > > > #ygrp-mlmsg #logo{ > > > > padding-bottom:10px;} > > > > > > > > #ygrp-vital{ > > > > background-color:#e0ecee;margin-bottom:20px;padding:2px 0 8px > 8px;} > > > > #ygrp-vital #vithd{ > > > > font-size:77%;font-family:Verdana;font- > weight:bold;color:#333;text- > > > transform:uppercase;} > > > > #ygrp-vital ul{ > > > > padding:0;margin:2px 0;} > > > > #ygrp-vital ul li{ > > > > list-style-type:none;clear:both;border:1px solid #e0ecee; > > > > } > > > > #ygrp-vital ul li .ct{ > > > > font-weight:bold;color:#ff7900;float:right;width:2em;text- > > > align:right;padding-right:.5em;} > > > > #ygrp-vital ul li .cat{ > > > > font-weight:bold;} > > > > #ygrp-vital a{ > > > > text-decoration:none;} > > > > > > > > #ygrp-vital a:hover{ > > > > text-decoration:underline;} > > > > > > > > #ygrp-sponsor #hd{ > > > > color:#999;font-size:77%;} > > > > #ygrp-sponsor #ov{ > > > > padding:6px 13px;background-color:#e0ecee;margin-bottom:20px;} > > > > #ygrp-sponsor #ov ul{ > > > > padding:0 0 0 8px;margin:0;} > > > > #ygrp-sponsor #ov li{ > > > > list-style-type:square;padding:6px 0;font-size:77%;} > > > > #ygrp-sponsor #ov li a{ > > > > text-decoration:none;font-size:130%;} > > > > #ygrp-sponsor #nc{ > > > > background-color:#eee;margin-bottom:20px;padding:0 8px;} > > > > #ygrp-sponsor .ad{ > > > > padding:8px 0;} > > > > #ygrp-sponsor .ad #hd1{ > > > > font-family:Arial;font-weight:bold;color:#628c2a;font- > > > size:100%;line-height:122%;} > > > > #ygrp-sponsor .ad a{ > > > > text-decoration:none;} > > > > #ygrp-sponsor .ad a:hover{ > > > > text-decoration:underline;} > > > > #ygrp-sponsor .ad p{ > > > > margin:0;} > > > > o{font-size:0;} > > > > .MsoNormal{ > > > > margin:0 0 0 0;} > > > > #ygrp-text tt{ > > > > font-size:120%;} > > > > blockquote{margin:0 0 0 4px;} > > > > .replbq{margin:4;} > > > > --> > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > __________________________________________________________ > > > ______________ > > > > Looking for last minute shopping deals? > > > > Find them fast with Yahoo! Search. > > > http://tools.search.yahoo.com/newsearch/category.php? > category=shopping > > > > > > > > > > > > > > > > --------------------------------- > Never miss a thing. Make Yahoo your homepage. > Looking for last minute shopping deals? Find them fast with Yahoo! Search. No virus found in this incoming message. Checked by AVG Free Edition. Version: 7.5.516 / Virus Database: 269.17.12/1203 - Release Date: 12/30/2007 11:27 AM Quote Link to comment Share on other sites More sharing options...
Guest guest Posted December 31, 2007 Report Share Posted December 31, 2007 , My Tai Chi instructor always taught me that the only stupid question is the one you don't ask. You can pretty much garantee that if you ask a question, no matter how minor it might seem to you, someone else is wanting to know the answer too. I You will never make a fool of yourself by asking a question, and I haven't come across anyone on here that will belittle you for asking. Some questions that others have asked on here are ones that I haven't even thought of, but reading the question, and the subsequent replies, I have found out that they are very relevant to me. I genuinely believe that the more knowledge we have about our condition the better quality of life we will have, and if that involves learning from someone else, that's fine. Getting an answer to a question can be the single flame in the dark. Please don't be afraid to ask Besides, I think Bruce likes the challange Love Ze xx> > > > >> > > > > Thanks ,> > > > > That was really informative and for me it answered the > > > > question of why prednisone works for some of us and not for > > others. > > > > I thought all forms of PF were inflammatory and didn't realize > > IPF > > > > was not. > > > > > > > > > > Sarcoid/PF 3/2006 California> > > > > > > > > > > > > > > PF and Raynauds Disease> > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > Long post here folks bear with me.> > > > > > > > > > > > > > > > > > > > Raynauds Syndrome is a vasospasmic disorder which affects > > between 5%> > > > > > > > > > to 10% of the US population. About 20% of women in their child > > > > bearing> > > > > > > > > > years are afflicted. The disorder is more common among women > > than > > > > men.> > > > > > > > > > > > > > > > > > > > There are two forms of the disease: > > > > > > > > > > > > > > > > > > > > Primary Raynauds is the most common form of the disease and > > usually > > > > is> > > > > > > > > > of earlier onset. It is called Raynauds Disease (RD). It is of > > > > unknown> > > > > > > > > > etiology. > > > > > > > > > > > > > > > > > > > > Secondary Raynauds is called Raynauds Phenomenon (RP). It is> > > > > > > > > > considered to be the more serious of the two and its onset is > > later > > > > in> > > > > > > > > > life (third decade and out). RP like many forms of PF is > > considered > > > > an> > > > > > > > > > inflammatory condition. Many forms of Pulmonary Fibrosis (PF), > > like > > > > RP> > > > > > > > > > , are co-morbid or secondary diseases. > > > > > > > > > > > > > > > > > > > > Known causes of both RP and/or PF are:> > > > > > > > > > > > > > > > > > > > Collagen Vascular Disease, Connective Tissue Disease, Rheumatic> > > > > > > > > > Disease, Atherosclerosis, Auto-Immune Disease, Repetitive Stress> > > > > > > > > > Injuries, Trauma, Smoking, Medication and Chemotherapy exposure,> > > > > > > > > > Chemical exposure and, some Endocrine and Hormonal disorders.> > > > > > > > > > > > > > > > > > > > It is quite possible that many of us on this Board suffer from > > RP > > > > and> > > > > > > > > > PF AND a PRIMARY co-morbid (co-existing) diagnosis. > > > > > > > > > > > > > > > > > > > > Last,in that UIP/IPF (usual interstitial pneumonitis / > > idiopathic> > > > > > > > > > pulmonary fibrosis)is NOT considered to be an inflammatory form > > of > > > > PF> > > > > > > > > > and, is of unknown etiology it follows that if you suffer from > > > > UIP/IPF> > > > > > > > > > and Raynauds it is more likely to be the less serious of the > > two RD> > > > > > > > > > and not RP.> > > > > > > > > > > > > > > > > > > > For me, my DX (5.06)is Usual Interstial Pneumonitis and > > Langerhans> > > > > > > > > > Cell Histiocytosis. I have had Raynauds Disease all my life. I > > find > > > > RD> > > > > > > > > > to be distracting and inconvenient but never anything more than > > > > that.> > > > > > > > > > > > > > > > > > > > UIP/LCH 5.06 CA> > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > <!--> > > > > > > > > > #ygrp-mkp{> > > > > border:1px solid #d8d8d8;font-family:Arial;margin:14px > > > > 0px;padding:0px 14px;}> > > > > #ygrp-mkp hr{> > > > > border:1px solid #d8d8d8;}> > > > > #ygrp-mkp #hd{> > > > > color:#628c2a;font-size:85%;font-weight:bold;line-> > > > height:122%;margin:10px 0px;}> > > > > #ygrp-mkp #ads{> > > > > margin-bottom:10px;}> > > > > #ygrp-mkp .ad{> > > > > padding:0 0;}> > > > > #ygrp-mkp .ad a{> > > > > color:#0000ff;text-decoration:none;}> > > > > -->> > > > > > > > > > > > > > > > > > > > <!--> > > > > > > > > > #ygrp-sponsor #ygrp-lc{> > > > > font-family:Arial;}> > > > > #ygrp-sponsor #ygrp-lc #hd{> > > > > margin:10px 0px;font-weight:bold;font-size:78%;line-> > height:122%;}> > > > > #ygrp-sponsor #ygrp-lc .ad{> > > > > margin-bottom:10px;padding:0 0;}> > > > > -->> > > > > > > > > > > > > > > > > > > > <!--> > > > > > > > > > #ygrp-mlmsg {font-size:13px;font-family:arial, helvetica, > > clean, > > > > sans-serif;}> > > > > #ygrp-mlmsg table {font-size:inherit;font:100%;}> > > > > #ygrp-mlmsg select, input, textarea {font:99% arial, helvetica, > > > > clean, sans-serif;}> > > > > #ygrp-mlmsg pre, code {font:115% monospace;}> > > > > #ygrp-mlmsg * {line-height:1.22em;}> > > > > #ygrp-text{> > > > > font-family:Georgia;> > > > > }> > > > > #ygrp-text p{> > > > > margin:0 0 1em 0;}> > > > > #ygrp-tpmsgs{> > > > > font-family:Arial;> > > > > clear:both;}> > > > > #ygrp-vitnav{> > > > > padding-top:10px;font-family:Verdana;font-size:77%;margin:0;}> > > > > #ygrp-vitnav a{> > > > > padding:0 1px;}> > > > > #ygrp-actbar{> > > > > clear:both;margin:25px 0;white-space:nowrap;color:#666;text-> > > > align:right;}> > > > > #ygrp-actbar .left{> > > > > float:left;white-space:nowrap;}> > > > > .bld{font-weight:bold;}> > > > > #ygrp-grft{> > > > > font-family:Verdana;font-size:77%;padding:15px 0;}> > > > > #ygrp-ft{> > > > > font-family:verdana;font-size:77%;border-top:1px solid #666;> > > > > padding:5px 0;> > > > > }> > > > > #ygrp-mlmsg #logo{> > > > > padding-bottom:10px;}> > > > > > > > > > #ygrp-vital{> > > > > background-color:#e0ecee;margin-bottom:20px;padding:2px 0 8px > > 8px;}> > > > > #ygrp-vital #vithd{> > > > > font-size:77%;font-family:Verdana;font-> > weight:bold;color:#333;text-> > > > transform:uppercase;}> > > > > #ygrp-vital ul{> > > > > padding:0;margin:2px 0;}> > > > > #ygrp-vital ul li{> > > > > list-style-type:none;clear:both;border:1px solid #e0ecee;> > > > > }> > > > > #ygrp-vital ul li .ct{> > > > > font-weight:bold;color:#ff7900;float:right;width:2em;text-> > > > align:right;padding-right:.5em;}> > > > > #ygrp-vital ul li .cat{> > > > > font-weight:bold;}> > > > > #ygrp-vital a{> > > > > text-decoration:none;}> > > > > > > > > > #ygrp-vital a:hover{> > > > > text-decoration:underline;}> > > > > > > > > > #ygrp-sponsor #hd{> > > > > color:#999;font-size:77%;}> > > > > #ygrp-sponsor #ov{> > > > > padding:6px 13px;background-color:#e0ecee;margin-bottom:20px;}> > > > > #ygrp-sponsor #ov ul{> > > > > padding:0 0 0 8px;margin:0;}> > > > > #ygrp-sponsor #ov li{> > > > > list-style-type:square;padding:6px 0;font-size:77%;}> > > > > #ygrp-sponsor #ov li a{> > > > > text-decoration:none;font-size:130%;}> > > > > #ygrp-sponsor #nc{> > > > > background-color:#eee;margin-bottom:20px;padding:0 8px;}> > > > > #ygrp-sponsor .ad{> > > > > padding:8px 0;}> > > > > #ygrp-sponsor .ad #hd1{> > > > > font-family:Arial;font-weight:bold;color:#628c2a;font-> > > > size:100%;line-height:122%;}> > > > > #ygrp-sponsor .ad a{> > > > > text-decoration:none;}> > > > > #ygrp-sponsor .ad a:hover{> > > > > text-decoration:underline;}> > > > > #ygrp-sponsor .ad p{> > > > > margin:0;}> > > > > o{font-size:0;}> > > > > .MsoNormal{> > > > > margin:0 0 0 0;}> > > > > #ygrp-text tt{> > > > > font-size:120%;}> > > > > blockquote{margin:0 0 0 4px;}> > > > > .replbq{margin:4;}> > > > > -->> > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > __________________________________________________________> > > > ______________> > > > > Looking for last minute shopping deals? > > > > > Find them fast with Yahoo! Search. > > > > http://tools.search.yahoo.com/newsearch/category.php?> > category=shopping> > > > >> > > >> > >> > > > > > > > > > > > > > ---------------------------------> > Never miss a thing. Make Yahoo your homepage.> >> > > > > > > ---------------------------------> Looking for last minute shopping deals? Find them fast with Yahoo! Search.> Quote Link to comment Share on other sites More sharing options...
Guest guest Posted December 31, 2007 Report Share Posted December 31, 2007 Tai Chi.....not for me. Maybe Mai Tai. Not only is every question welcome and perhaps I do like the challenge but I can assure you I learn far more here every day than I share and I thought 's answer was excellent and nice to see an overseas perspective. And, she did point out the evolving confusion. Actually the various forms here are individually identified by specific pathologies as among the 6 or so most common ILD's there are definite distinguishing pathological features. I learn not only from the answers of others but from continued research before I answer any question. As I double check my answers, I often find one additional piece of information I didn't know. I've also asked more than my share of questions, many about the practical issues that the experienced here long ago worked through, whether it be type of oxygen delivery systems, cannulas, oxyview glasses, humidification, water traps, traveling, or who knows what. There are still thousands of aspects of this disease I've yet to experience. I also gained input into VATS from those who had actually had them to combine with my doctors' input before having mine and have listened and read comments on prednisone to reconfirm in my mind that I've made the right decision for me. Bruce Moreland 58 IPF 08/07 Dallas/Plano > > > > > > > > > > > > Thanks , > > > > > > That was really informative and for me it answered the > > > > > question of why prednisone works for some of us and not for > > > others. > > > > > I thought all forms of PF were inflammatory and didn't realize > > > IPF > > > > > was not. > > > > > > > > > > > > Sarcoid/PF 3/2006 California > > > > > > > > > > > > > > > > > > PF and Raynauds Disease > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > Long post here folks bear with me. > > > > > > > > > > > > > > > > > > > > > > > > Raynauds Syndrome is a vasospasmic disorder which affects > > > between 5% > > > > > > > > > > > > to 10% of the US population. About 20% of women in their child > > > > > bearing > > > > > > > > > > > > years are afflicted. The disorder is more common among women > > > than > > > > > men. > > > > > > > > > > > > > > > > > > > > > > > > There are two forms of the disease: > > > > > > > > > > > > > > > > > > > > > > > > Primary Raynauds is the most common form of the disease and > > > usually > > > > > is > > > > > > > > > > > > of earlier onset. It is called Raynauds Disease (RD). It is of > > > > > unknown > > > > > > > > > > > > etiology. > > > > > > > > > > > > > > > > > > > > > > > > Secondary Raynauds is called Raynauds Phenomenon (RP). It is > > > > > > > > > > > > considered to be the more serious of the two and its onset is > > > later > > > > > in > > > > > > > > > > > > life (third decade and out). RP like many forms of PF is > > > considered > > > > > an > > > > > > > > > > > > inflammatory condition. Many forms of Pulmonary Fibrosis (PF), > > > like > > > > > RP > > > > > > > > > > > > , are co-morbid or secondary diseases. > > > > > > > > > > > > > > > > > > > > > > > > Known causes of both RP and/or PF are: > > > > > > > > > > > > > > > > > > > > > > > > Collagen Vascular Disease, Connective Tissue Disease, > Rheumatic > > > > > > > > > > > > Disease, Atherosclerosis, Auto-Immune Disease, Repetitive > Stress > > > > > > > > > > > > Injuries, Trauma, Smoking, Medication and Chemotherapy > exposure, > > > > > > > > > > > > Chemical exposure and, some Endocrine and Hormonal disorders. > > > > > > > > > > > > > > > > > > > > > > > > It is quite possible that many of us on this Board suffer from > > > RP > > > > > and > > > > > > > > > > > > PF AND a PRIMARY co-morbid (co-existing) diagnosis. > > > > > > > > > > > > > > > > > > > > > > > > Last,in that UIP/IPF (usual interstitial pneumonitis / > > > idiopathic > > > > > > > > > > > > pulmonary fibrosis)is NOT considered to be an inflammatory > form > > > of > > > > > PF > > > > > > > > > > > > and, is of unknown etiology it follows that if you suffer from > > > > > UIP/IPF > > > > > > > > > > > > and Raynauds it is more likely to be the less serious of the > > > two RD > > > > > > > > > > > > and not RP. > > > > > > > > > > > > > > > > > > > > > > > > For me, my DX (5.06)is Usual Interstial Pneumonitis and > > > Langerhans > > > > > > > > > > > > Cell Histiocytosis. I have had Raynauds Disease all my life. I > > > find > > > > > RD > > > > > > > > > > > > to be distracting and inconvenient but never anything more > than > > > > > that. > > > > > > > > > > > > > > > > > > > > > > > > UIP/LCH 5.06 CA > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > <!-- > > > > > > > > > > > > #ygrp-mkp{ > > > > > > border:1px solid #d8d8d8;font-family:Arial;margin:14px > > > > > 0px;padding:0px 14px;} > > > > > > #ygrp-mkp hr{ > > > > > > border:1px solid #d8d8d8;} > > > > > > #ygrp-mkp #hd{ > > > > > > color:#628c2a;font-size:85%;font-weight:bold;line- > > > > > height:122%;margin:10px 0px;} > > > > > > #ygrp-mkp #ads{ > > > > > > margin-bottom:10px;} > > > > > > #ygrp-mkp .ad{ > > > > > > padding:0 0;} > > > > > > #ygrp-mkp .ad a{ > > > > > > color:#0000ff;text-decoration:none;} > > > > > > --> > > > > > > > > > > > > > > > > > > > > > > > > <!-- > > > > > > > > > > > > #ygrp-sponsor #ygrp-lc{ > > > > > > font-family:Arial;} > > > > > > #ygrp-sponsor #ygrp-lc #hd{ > > > > > > margin:10px 0px;font-weight:bold;font-size:78%;line- > > > height:122%;} > > > > > > #ygrp-sponsor #ygrp-lc .ad{ > > > > > > margin-bottom:10px;padding:0 0;} > > > > > > --> > > > > > > > > > > > > > > > > > > > > > > > > <!-- > > > > > > > > > > > > #ygrp-mlmsg {font-size:13px;font-family:arial, helvetica, > > > clean, > > > > > sans-serif;} > > > > > > #ygrp-mlmsg table {font-size:inherit;font:100%;} > > > > > > #ygrp-mlmsg select, input, textarea {font:99% arial, > helvetica, > > > > > clean, sans-serif;} > > > > > > #ygrp-mlmsg pre, code {font:115% monospace;} > > > > > > #ygrp-mlmsg * {line-height:1.22em;} > > > > > > #ygrp-text{ > > > > > > font-family:Georgia; > > > > > > } > > > > > > #ygrp-text p{ > > > > > > margin:0 0 1em 0;} > > > > > > #ygrp-tpmsgs{ > > > > > > font-family:Arial; > > > > > > clear:both;} > > > > > > #ygrp-vitnav{ > > > > > > padding-top:10px;font-family:Verdana;font- size:77%;margin:0;} > > > > > > #ygrp-vitnav a{ > > > > > > padding:0 1px;} > > > > > > #ygrp-actbar{ > > > > > > clear:both;margin:25px 0;white- space:nowrap;color:#666;text- > > > > > align:right;} > > > > > > #ygrp-actbar .left{ > > > > > > float:left;white-space:nowrap;} > > > > > > .bld{font-weight:bold;} > > > > > > #ygrp-grft{ > > > > > > font-family:Verdana;font-size:77%;padding:15px 0;} > > > > > > #ygrp-ft{ > > > > > > font-family:verdana;font-size:77%;border-top:1px solid #666; > > > > > > padding:5px 0; > > > > > > } > > > > > > #ygrp-mlmsg #logo{ > > > > > > padding-bottom:10px;} > > > > > > > > > > > > #ygrp-vital{ > > > > > > background-color:#e0ecee;margin-bottom:20px;padding:2px 0 8px > > > 8px;} > > > > > > #ygrp-vital #vithd{ > > > > > > font-size:77%;font-family:Verdana;font- > > > weight:bold;color:#333;text- > > > > > transform:uppercase;} > > > > > > #ygrp-vital ul{ > > > > > > padding:0;margin:2px 0;} > > > > > > #ygrp-vital ul li{ > > > > > > list-style-type:none;clear:both;border:1px solid #e0ecee; > > > > > > } > > > > > > #ygrp-vital ul li .ct{ > > > > > > font-weight:bold;color:#ff7900;float:right;width:2em;text- > > > > > align:right;padding-right:.5em;} > > > > > > #ygrp-vital ul li .cat{ > > > > > > font-weight:bold;} > > > > > > #ygrp-vital a{ > > > > > > text-decoration:none;} > > > > > > > > > > > > #ygrp-vital a:hover{ > > > > > > text-decoration:underline;} > > > > > > > > > > > > #ygrp-sponsor #hd{ > > > > > > color:#999;font-size:77%;} > > > > > > #ygrp-sponsor #ov{ > > > > > > padding:6px 13px;background-color:#e0ecee;margin- bottom:20px;} > > > > > > #ygrp-sponsor #ov ul{ > > > > > > padding:0 0 0 8px;margin:0;} > > > > > > #ygrp-sponsor #ov li{ > > > > > > list-style-type:square;padding:6px 0;font-size:77%;} > > > > > > #ygrp-sponsor #ov li a{ > > > > > > text-decoration:none;font-size:130%;} > > > > > > #ygrp-sponsor #nc{ > > > > > > background-color:#eee;margin-bottom:20px;padding:0 8px;} > > > > > > #ygrp-sponsor .ad{ > > > > > > padding:8px 0;} > > > > > > #ygrp-sponsor .ad #hd1{ > > > > > > font-family:Arial;font-weight:bold;color:#628c2a;font- > > > > > size:100%;line-height:122%;} > > > > > > #ygrp-sponsor .ad a{ > > > > > > text-decoration:none;} > > > > > > #ygrp-sponsor .ad a:hover{ > > > > > > text-decoration:underline;} > > > > > > #ygrp-sponsor .ad p{ > > > > > > margin:0;} > > > > > > o{font-size:0;} > > > > > > .MsoNormal{ > > > > > > margin:0 0 0 0;} > > > > > > #ygrp-text tt{ > > > > > > font-size:120%;} > > > > > > blockquote{margin:0 0 0 4px;} > > > > > > .replbq{margin:4;} > > > > > > --> > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > __________________________________________________________ > > > > > ______________ > > > > > > Looking for last minute shopping deals? > > > > > > Find them fast with Yahoo! Search. > > > > > http://tools.search.yahoo.com/newsearch/category.php? > > > category=shopping > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > --------------------------------- > > > Never miss a thing. Make Yahoo your homepage. > > > > > > > > > > > > > > > > > --------------------------------- > > Looking for last minute shopping deals? Find them fast with Yahoo! > Search. > > > Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.